08.08.2013
CURRICULUM VITAE
Gang Hu, MD, MPH, PhD, FAHA, Assistant Professor
OFFICE ADDRESS:
EDUCATION:
2005
Chronic Disease Epidemiology Laboratory
Pennington Biomedical Research Center
Louisiana State University System
6400 Perkins Road
Baton Rouge, Louisiana 70808
Tel: (225) 763-3053
Fax: (225) 763-3009
Email: gang.hu@pbrc.edu
Adjunct professor (Docent), University of Helsinki, Finland (Field: Public Health)
2001
Ph.D. Faculty of Medicine, University of Kuopio, Finland (Field: Sport Medicine)
2000
M.P.H. Faculty of Medicine, University of Kuopio, Finland (Field: Public Health)
1989
M.D. Tianjin Medical University, P. R. China (Field: Nutrition/Public Health)
POSTDOCTORAL TRAINING:
2001-2003
Post-doctor fellow, Department of Epidemiology and Health Promotion, National
Public Health Institute, Helsinki, and Department of Public Health, University of
Helsinki, Finland
2003-2005
Academy postdoctoral researcher, Academy of Finland, Helsinki, Finland
PROFESSIONAL EXPERIENCE:
2010-present Adjunct assistant professor, Epidemiology Program, School of Public Health,
Louisiana State University Health Sciences Center (LSUHSC) – New Orleans
2010-present Adjunct assistant professor, the Graduate School, Louisiana State University
2010-present Adjunct assistant professor, School of Human Ecology, Louisiana State University
2009-present Assistant professor & Director, Chronic Disease Epidemiology Laboratory,
Pennington Biomedical Research Center, Louisiana State University System
2007-present Guest professor, Tianjin Women’s and Children’s Health Center, Tianjin, China
2005-precent Adjunct professor (Docent) of Public Health, University of Helsinki, Finland
2004-2008
Senior researcher, Department of Epidemiology and Health Promotion, National
Public Health Institute, Helsinki, and Department of Public Health, University of
Helsinki, Finland
2003-2005
Senior academy postdoctoral researcher, Academy of Finland, Finland
2001-2003
Post-doctor research fellow, Department of Epidemiology and Health Promotion,
National Public Health Institute, Helsinki, and Department of Public Health, University
of Helsinki, Finland
1998-2001
Researcher and postgraduate student for Ph.D., Departments of Physiology and
Public Health and General Practice, University of Kuopio, Finland
1995-1998
Senior researcher, Department of Nutrition, Food Safety Control and Inspection
Institute, Tianjin, P. R. China
1989-1995
Researcher, Department of Nutrition, Food Safety Control and Inspection Institute,
Tianjin, P. R. China
PROFESSIONAL ACTIVITIES:
Society Membership:
 Principal of Chinese Language School of Baton Rouge (2013)
 Vice president of the Chinese Friendship Association of Baton Rouge (2013)
 American Diabetes Association (2009-)
 American Heart Association (2009-)
 American Stroke Association (2009-)
 European Association for the Study of Diabetes (European Diabetes Epidemiology Group)
(2001-)
 European Association for Cardiovascular Prevention and Rehabilitation (2005-)
 European Society of Hypertension (2006-2010)
 Finnish Hypertension Society (2006-)
 The International Diabetes Federation (International Diabetes Epidemiology Group) (2003-)
Member of the Editorial Board for the Scientific Journals:
 Current Diabetes Reviews (2004-)
 Obesity Research, Guest Editor (2006)
 The Open General & Internal Medicine Reviews (OGMR) (2007-2010)
 The Open Hematology Journal (2007-)
 ClinicoEconomics & Outcomes Research (2008-)
 Nutrition and Metabolic Insights (2008-)
 The Open Diabetes Journal (2008-)
 The Open Hypertension Journal (2008-)
 World Journal of Diabetes (2009-)
 Journal of Geriatric Cardiology (2011-)
 American Journal of Cardiovascular Disease (2011-)
 Open Journal of Pediatrics (2011-)
 World Journal of Hypertension (2012-)
Regular Reviewer for the Following Scientific Journals:
 American Journal of Cardiovascular Drugs (2007)
 American Journal of Epidemiology (2004-2013)
 American Journal of Hypertension (2004-2007)
 Annals of Internal Medicine (2006, 2013)
 Annals of Nutrition and Metabolism (2007)
 Archives of General Psychiatry (2011)
 Asia Pacific Journal of Clinical Nutrition (2011, 2012)
 Atherosclerosis (2006, 2008, 2010, 2012)
 BMC Pregnancy and Childbirth (2013)
 BMC Public Health (2006-2008)
 BMJ Open (2011)
 Bone (2013)
 British Journal of Nutrition (2009, 2010)




















































British Journal of Sports Medicine (2006, 2007)
British Medical Journal (2010)
Cancer Detection and Prevention (2007)
Cardiovascular Diabetology (2009)
Circulation (2005-2013)
Clinica Chimica Acta (2004)
Clinical Endocrinology (2006)
Current Diabetes Reviews (2004-2010)
Current Pharmaceutical Design (2007)
Diabetes Care (2006-2013)
Diabetic Medicine (2002, 2003, 2004, 2006)
Diabetes Research and Clinical Practice (2004-2007, 2009, 2011)
Diabetes & Metabolism (2006)
Diabetes, Obesity and Metabolism (2011, 2012)
Diabetologia (2005, 2007, 2012)
Endocrine-Related Cancer (2012)
European Heart Journal (2006-2009)
European Journal of Cardiovascular Prevention and Rehabilitation (2006-2008)
European Journal of Clinical Nutrition (2006)
European Journal of Epidemiology (2006, 2008)
European Journal of Heart Failure (2012)
European Journal of Internal Medicine (2008)
European Journal of Neurology (2008)
Gender Medicine (2005, 2008)
Gynecologic and Obstetric Investigation (2011)
Hepatology (2009)
Hormone and Metabolic Research (2004)
Hypertension (2006, 2007)
International Diabetes Monitor (2003)
International Journal of Behavioral Nutrition and Physical Activity (2004)
International Journal of Medical Sciences (2006)
International Journal of Obesity and Related Metabolic Disorders (2004)
Journal of Diabetes and Its Complications (2002, 2008)
Journal of Internal Medicine (2006)
Journal of Physical Activity and Health (2007)
Journal of the Academy of Nutrition and Dietetics (2012)
Journal of the Neurological Sciences (2007, 2008)
Journal of Women's Health (2007)
Mediators of inflammation (2013)
Medicine and Science in Sports and Exercise (2002, 2007, 2008)
Medical Science Monitor (2007)
Metabolic Syndrome and Related Disorders (2007)
Movement Disorders (2007, 2008)
Neurology (2008, 2009, 2011, 2012)
Nutrition Journal (2011)
Nutrition, Metabolism & Cardiovascular Diseases (2009)
Obesity (2004-2007, 2011-2013)
Obesity Review (2011)
Open General & Internal Medicine Reviews (2007, 2009)
Open Journal of Pediatrics (2011)
PLoS ONE (2010-2012)
Preventing Chronic Disease (2008)

















Preventive Medicine (2005-2010)
Primary Care Diabetes (2012)
Public Health Nutrition (2005)
Social Science & Medicine (2003, 2008)
Sport Medicine (2007)
Stroke (2005-2007, 2012, 2013)
The American Journal of Cardiology (2007, 2008)
The Journal of the American College of Nutrition (JACN) (2007)
The Journal of Clinical Endocrinology & Metabolism (2011, 2012)
The Journal of the American Medical Association (JAMA) (2004, 2007, 2009, 2011, 2013)
JAMA Internal Medicine (Formerly Archive of Internal Medicine) (2007, 2012, 2013)
The Lancet (2008)
The Lancet Diabetes & Endocrinology (2013)
The Open Diabetes Journal (2010)
The Open Hematology Journal (2008)
Vascular Health and Risk Management (2008)
World Journal of Cardiology (2013)
Regular Reviewer for Grants:
 2013
American Heart Association: Genomics & Translational Epidemiology &
Observational Epidemiology – Population Science (Spring)
 2013
Diabetes Foundation – Diabetes UK: Project Grant
 2012
Medical Research Council, UK: Fellowships
 2012
Diabetes Foundation – Diabetes UK: Project Grant
 2012
American Heart Association: Behavioral Science Peer Review Study Group (Spring
and Fall)
 2011
Diabetes Foundation – Diabetes UK: Project Grant
 2008
The Chinese University of Hong Kong – Hong Kong Research Grants Council
 2006
Diabetes Foundation – Diabetes UK: Senior Research Fellowship
Member of the Abstract Reviewing Committee for Scientific Congress:
 2012
17th World Congress on Heart Disease, Toronto, ON, Canada, July 27-30, 2012
 2011
16th World Congress on Heart Disease, Vancouver, BC, Canada, July 23-26, 2011
 2009
European Society of Cardiology (ESC) Congress
 2008
European Society of Cardiology (ESC) Congress
Reviewer of Professor Promotion:
 2011
Full Professor (Researcher), Zhejiang University, China
Official Reviewer for PhD Student Thesis
 2010
Tomi Makinen, University of Helsinki: Trends and Explanations for Socioeconomic
Differences in Physical Activity
Scientific Supervision (Post-Doc, PhD and Master):
Official Supervisor (Post-Doc):
 On-going Amanda Staiano, Pennington Biomedical Research Center (co-mentors with Dr. Peter
Katzmarzyk)
 On-going Wenhui Zhao, Pennington Biomedical Research Center
 2012-13 Jing Guan, Pennington Biomedical Research Center
 2010-11 Yurong Zhang, Pennington Biomedical Research Center
Official Supervisor (PhD):


On-going Ding Ding, Pennington Biomedical Research Center/School of Public Health, Sun
Yat-Sen University, Guangzhou, China
2010-13 Yujie Wang, School of Human Ecology, Louisiana State University: Lifestyle factors
and the risk of heart failure (Committees Chair)
Official Supervisor (Master):
 2011-12 Yujie Wang, Department of Experimental Statistics, Louisiana State University
(Committees Member)
 2010-12 Wei Li, Department of Experimental Statistics, Louisiana State University
 2011
Lu Zhang, Epidemiology Program, School of Public Health, Louisiana State
University Health Sciences Center (Summer trainee)
 2010-11 Yujie Wang, School of Human Ecology, Louisiana State University: A cohort study of
gestational diabetes mellitus and the risk of incident type 2 diabetes in Louisiana
women (Committees Chair)
 2011
Wenting Xie, Department of Experimental Statistics, Louisiana State University
(Committees Member)
Official Supervisor (Visiting Scholar):
 On-going Weiqin Li, Pennington Biomedical Research Center
 On-going Ding Ding, Pennington Biomedical Research Center
 2012-13 Nan Li, Pennington Biomedical Research Center
 2013
Mei Shi, Pennington Biomedical Research Center
Non-official Supervisor (PhD):
 2008
Siamak Bidel, University of Helsinki: Coffee and risk of type 2 diabetes
 2006
Noel Barengo, University of Kuopio: Physical activity, cardiovascular risk factors and
mortality
 2005
Jianjun Wang, University of Helsinki: Assessment of the metabolic syndrome in
predicting incident type 2 diabetes in a Chinese population
Invited Lecture at Universities, Institutes or Scientific Congress:
 06/24/13 “Tianjin Gestational Diabetes Prevention Program”, Department of Preventive
Medicine, Northwestern University Feinberg School of Medicine
 10/27/12 “Mothers and Children Health”, Chinese Symposium on Adverse Intrauterine
Environment and Fetal Origins of Disease, Department of Health Sciences, Natural
Science Foundation of China, Wuhan, China, October 26-28, 2012
 10/23/12 “Tianjin Gestational Diabetes Prevention Program”, School of Public Health, Sun
Yat-Sen University, Guangzhou, China
 10/18/12 “Tianjin Women and Children Health Program”, Epidemiology-Asia Pacific Unit, Merck
Research Laboratories, Beijing, China
 07/29/12 “Lifestyle factors and the risk of stroke”, 17th World Congress on Heart Disease,
Annual Scientific Sessions 2012, Toronto, ON, Canada, July 27-30, 2012
 08/22/11 “Mother and Children Health in China”, Global Health Policy Cohort Management
Advisory Board Meeting, The Hague, Netherlands, August 21-22, 2011.
 08/15/11 “Mothers with Gestational Diabetes and Their Children Health”, Department of
Population, Medicine Harvard Medical School/Harvard Pilgrim Health Care Institute,
Boston.
 06/03/11 “Prevention of Chronic Diseases”, School of Public Health, Sun Yat-sen University,
Guangzhou, China
 06/18/10 “Exercise, Body Weight and Cardiovascular Risk”, and The China Health
Communications Award Program (Balance between Diet & Exercises 2010) KOLs Media Knowledge Sharing Meeting, Beijing, China
 06/18/10 “Exercise, Obesity and Health”, National Institute of Sport Medicine, Beijing, China
 06/17/10 “Cardiovascular disease and exercise”, The Chinese Society of Cardiology - China

03/17/10

03/10/10

04/29/09




10/04/06
2005-08
2000
1995
CDC - Ministry of Health Joint Session “CVD Prevention and Control: from Research
to Action”, World Congress of Cardiology Scientific Sessions 2010, Beijing, China,
June 16-19, 2010
“Physical activity, obesity and metabolic health”, School of Public Health, Louisiana
State University Health Science Center
“Physical activity and the risk of metabolic disease”, Department of Kinesiology,
Louisiana State University (course KIN 7999)
“Joint effects of physical activity and body weigh on the risk of several chronic
diseases”, School of Human Ecology, Louisiana State University
Coffee Roaster’s Association, Finland
University of Helsinki, Finland
University of Kuopio, Finland
Tianjin Medical University, P. R. China
Faculty or International Advisory Board at Scientific Congress:
 07/2012 Scientific Advisory Board, 17th World Congress on Heart Disease, Annual Scientific
Sessions 2012, Toronto, ON, Canada, July 27-30, 2012
 07/2011 Scientific Advisory Board, 16th World Congress on Heart Disease, Annual Scientific
Sessions 2011, Vancouver, BC, Canada, July 23-26, 2011
 07/2010 Scientific Advisory Board, 15th World Congress on Heart Disease, Annual Scientific
Sessions 2010, Vancouver, BC, Canada, July 24-27, 2010
 06/2010 Faculty, World Congress of Cardiology Scientific Sessions 2010, Beijing, China, June
16-19, 2010
Organization at Scientific Congress:
 10/27/12 Session Chairs, “Screening and Prevention”, Chinese Symposium on Adverse
Intrauterine Environment and Fetal Origins of Disease by Department of Health
Sciences, Natural Science Foundation of China, Wuhan, China, October 26-28, 2012
 06/2010 The Chinese Society of Cardiology - China CDC - Ministry of Health Joint Session
Chairs, “CVD Prevention and Control: from Research to Action”, World Congress of
Cardiology Scientific Sessions 2010, Featuring the 3rd International Conference on
Women, Heart Disease and Stroke, Beijing, China, June 16-19, 2010
International Training:
 2005
WHO/Euro CINDI Programme: The CINDI Winter School, National Public Health
Institute, Helsinki, Finland
 2005
Summer School of the European Society of Hypertension, Visegrad, Hungary
 2003
The 8th Cambridge WHO/IDF Seminar on the Epidemiology and Public Health
Aspects of Diabetes, Cambridge, UK
 1999
International Visitors’ Programme of the North Karelia Project in Finland,
National Public Health Institute, Helsinki, Finland
TEACHING EXPERIENCE/RESPONSIBILITIES:
In US

03/2010

03/2010

04/2009
In Finland
Lecture on “Physical activity, obesity and metabolic health”, Epidemiology Seminar,
School of Public Health, Louisiana State University Health Science Center
Lecture on “Physical activity and the risk of metabolic disease”, Department of
Kinesiology, Louisiana State University (course KIN 7999)
Lecture on “Joint effects of physical activity and body weigh on the risk of several
chronic diseases”, Human Nutrition and Food Seminar School of Human Ecology,
Louisiana State University

2005-2008 Lecture on “Health Status in China”, Cardiovascular Epidemiology (Course for PhD
students), University of Helsinki, Finland
RESEARCH GRANTS AND CONTRACTS:
Ongoing
Project
Huiguang Tian/Gang Hu
07/01/2013-12/31/2015
European Foundation for the Study of Diabetes (EFSD)/Chinese Diabetes Society (CDS)/Lilly Program for
Collaborative Research between China and Europe
Tianjin gestational diabetes prevention program follow-up study
Role: Co-Principal Investigator (acting Principal Investigator – EFSD only allows PI from China)
Amanda Staiano
07/01/2013-06/30/2014
Louisiana Clinical and Translational Science (LA CaTS) Center Meritorious Postdoctoral Scholars
Race Disparities in Pediatric Type 2 Diabetes: The Role of Fat Distribution
Role: Co-mentors
Project
Ron Horswell/Gang Hu
03/01/2012-02/28/2014
LSU’s Improving Clinical Outcomes Network Pilot Grant
Designing Screening Protocols for Diabetes and Pre-diabetes
Role: Co-Principal Investigator
PBRC 2012-146
Peter Katzmarzyk
07/01/2013-06/30/2014
Louisiana State University System Health Care Services Division
LSU’s Improving Clinical Outcomes Network
Role: Senior Epidemiologist (Director) in Baton Rouge Epidemiological Research Team
PBRC 2010-352
P. Katzmarzyk/T. Church
01/01/2011-12/31/2014
Coca-Cola Foundation
International Study of Childhood Obesity, Lifestyle and the Environment (ISCOLE)
Role: China-site Principal Investigator
LT09-227
Huiguang Tian/Xilin Yang
07/01/2010-12/31/2013
International Diabetes Federation - Bringing Research in Diabetes to Global Environments and Systems
(BRIDGES)
A randomized translational study to examine the effects of shared care versus usual care in management of
gestational diabetes in a three-tier prenatal care network in Tianjin
Role: Senior Investigator
Completed
PBRC 2012-146
Peter Katzmarzyk
11/01/2011-06/30/2013
Louisiana State University System Health Care Services Division
LSU’s Improving Clinical Outcomes Network
Role: Senior Epidemiologist (Director) in Baton Rouge Epidemiological Research Team
Project
Huiguang Tian/Gang Hu
03/01/2009-06/30/2013
European Foundation for the Study of Diabetes (EFSD)/Chinese Diabetes Society (CDS)/Lilly Program for
Collaborative Research between China and Europe
A study of the interaction in lifestyle and genetic factors on the incidence of type 2 diabetes in Chinese
women with gestational diabetes after delivery
Role: Co-Principal Investigator (acting Principal Investigator – EFSD only allows PI from China)
Award
Gang Hu
03/01/2011-12/31/2012
American Heart Association Mark Bieber Award
Lifestyle factors in relation to heart failure
This project will assess the association between lifestyle factors and the risk of heart failure
Role: Principal Investigator
Project
Gang Hu
09/01/2009-12/31/2011
Merck
Association of high-density lipoprotein cholesterol with the risk of incident
disease/cardiovascular disease by different levels of low-density lipoprotein cholesterol
Role: Principal Investigator
coronary
heart
Project
Jaakko Tuomilehto
10/01/2009-09/30/2011
Finnish Cancer Foundation
Prospective analysis of lifestyle factors and cancer risk in Finnish cohorts of middle-aged people
Role: Co-Principal Investigator
Project
Jaakko Tuomilehto
01/01/2010-12/31/2010
Juho Vainio Foundation, Finland
Prospective analysis of lifestyle factors and cancer risk in Finnish cohorts of middle-aged people
Role: Co-Principal Investigator
Project
Pekka Jousilahti
01/01/2007-12/31/2010
Academy of Finland
Dietary, Lifestyle, and Genetic Determinants of Obesity and Metabolic Syndrome (DILGOM)
Role: Senior Investigator
Project
Jaakko Tuomilehto
01/01/2009-12/31/2009
Juho Vainio Foundation, Finland
Prospective analysis of lifestyle factors and cancer risk in Finnish cohorts of middle-aged people
Role: Co-Principal Investigator
Project
Jaakko Tuomilehto
10/01/2008-09/30/2009
Finnish Cancer Foundation
Prospective analysis of lifestyle factors and cancer risk in Finnish cohorts of middle-aged people
Role: Co-Principal Investigator
Project
Noel Barengo
05/01/2008-12/31/2009
Finnish Heart Association
Trends of glucose metabolism disorders, treatment of hypertension and its effects over time regarding
cardiovascular disease, stroke and all-cause mortality
Role: Co-Principal Investigator
Project
Gang Hu
05/01/2006-12/31/2008
Finnish Heart Association
The role of physical activity in cardiovascular disease prevention
Role: Principal Investigator
Project
Gang Hu
05/01/2005-12/31/2007
Finnish Heart Association
Diabetes, myocardial infraction, hypertension and other cardiovascular risk factors on the risk of coronary
mortality and stroke incidence and stroke mortality
Role: Principal Investigator
Project
Jaakko Tuomilehto
The Finnish Parkinson Foundation
05/01/2005-12/31/2006
Lifestyle factors and the risk of Parkinson’s disease
Role: Co-Principal Investigator
Project
Jaakko Tuomilehto
Juho Vainio Foundation, Finland
Coffee drinking and the risk of type 2 diabetes
Role: Co-Principal Investigator
01/01/2005-12/31/2006
Project
Jaakko Tuomilehto
10/01/2004-09/30/2006
AstraZeneca R&D Mölndal, Sweden
Diabetes, impaired glucose tolerance, dyslipidemia and mortality in European population
Role: Co-Principal Investigator
Project 204274
Gang Hu
01/08/2003-12/31/2005
Academy of Finland
Epidemiology of the metabolic syndrome in Finland and Europe
Role: Principal Investigator
Project 205657
Gang Hu
01/08/2003-12/31/2005
Academy of Finland
Epidemiology of the metabolic syndrome in Finland and Europe
Role: Principal Investigator
Project
Jaakko Tuomilehto
01/01/2003-12/31/2004
AstraZeneca R&D Mölndal, Sweden
The prevalence of the metabolic syndrome in the general population and its relation to morbidity and
mortality
Role: Co-Principal Investigator
Project 53585
Pekka Jousilahti
Academy of Finland
The health consequences of obesity in Finland
Role: Senior Investigator
01/01/2001-31/12/2003
AWARDS OR HONORS:
 2013
Top Papers Published for 2012 in the Category of Population Science from the
Journal Hypertension (Lifestyle factors and antihypertensive treatment on the risks of
stroke and its subtype. Hypertension 2012; 60: 906-912)
 2012
Sandra Daugherty Award for Excellence in Cardiovascular Disease or Hypertension
Epidemiology (Finalist). American Heart Association
 2011
Fellow. American Heart Association
 2011
The Mark Bieber Award. American Heart Association
 2009
Article (Hepatology 2008;48:129-136) was selected for Faculty of 1000 Medicine.
 2009
Article (International Journal of Obesity 2008;32:975-984) was listed the top 1 most
downloaded highlights from the international website of Nature China of 2008.
 2007
Marquis Who’s Who in the World, 25th edition
 2005
The Ralph S. Paffenbarger Jr. Poster Award (the second Finalist). International XVIII
Puijo Symposium, Kuopio, Finland
 2001
Honorary Member of the Order of the Horse Collar Knights, University of Kuopio,
Finland
 1984-89 Scholarship Award for Outstanding Students, Tianjin Medical University, China
TRAINEE HONORS:
 2012
PhD Student, Yujie Wang, 2012 Chinese Government Award for Outstanding Selffinanced Students Abroad by China Scholarship Council.

2012
Postdoctoral Fellow, Yurong Zhang, 2012 Outstanding Article of Shanxi Province
Natural Science
PUBLICATIONS
Peer-reviewed Journal Articles (impact factors)
1.
Ding D, Qiu J, Li X, Li D, Xia M, Li Z, Su D, Zhang J, Lv X, Xiao Y, Hu G, Ling W. Hyperglycemia and
mortality among patients with coronary artery disease. Diabetes Care, revised manuscript. (7.735).
2.
Li N, Liu E, Guo J, Pan L, Li B, Wang P, Liu J, Wang Y, Liu G, Hu G. Maternal gestational weight gain
on pregnancy outcomes and offspring anthropometrics in early infancy. PLoS One, revised
manuscript. (3.73)
3.
Liu G, Li N, Sun S, MD, Wen J, Lv F, Gao W, Li L, Chen F, Hu G. Maternal OGTT glucose levels at
26-30 gestational weeks with offspring growth and development in early infancy. Diabetic Medicine,
revised manuscript. (3.241)
4.
Wang Y, Katzmarzyk PT, Horswell R, Zhao W, Johnson J, Hu G. Kidney function and the risk of
cardiovascular disease in patients with Type 2 diabetes. Kidney International, revised manuscript.
(7.916)
5.
Zhao W, Katzmarzyk PT, Horswell R, Wang Y, Johnson J, Hu G. HbA1c and coronary heart disease
risk among diabetic patients. Diabetes Care, revised manuscript. (7.735).
6.
Christian P, Lee SE, Angel MD, Adair LS, Arifeen SE, Ashorn P, Barros FC, Fall CH, Fawzi WW, Hao
W, Hu G, Humphrey JH, Huybregts L, Joglekar CV, Kariuki SK, Kolsteren P, Krishnaveni GV, Liu E,
Martorell R, Osrin D, Persson LA, Ramakrishnan U, Richter L, Roberfroid D, Sania A, Kuile FO,
Tielsch J, Victora CG, Yajnik CS, Yan H, Zeng L, Black RE. Risk of childhood undernutrition related to
small-for-gestational age and preterm birth in low- and middle-income countries. International Journal
of Epidemiology, accepted. (6.982)
7.
Hu G, Heymsfield SB. Does overweight and obesity decrease mortality risk in diabetes? Journal of
General Internal Medicine, accepted. (3.278)
8.
Hu G, Tuomilehto J. Preventive effect of exercise on diabetes. Drug Discovery Today: Disease
Mechanisms, accepted.
9.
Katzmarzyk PT, Hu G, Cefalu WT, Mire E, Bouchard C. The importance of waist circumference and
body mass index for mortality risk in diabetic adults. Diabetes Care, accepted. (7.735).
10.
Wang Y, Lammi-Keefe CJ, Hou L, Hu G. Impact of low-density lipoprotein cholesterol on
cardiovascular outcomes in persons with type 2 diabetes: a meta-analysis of prospective studies.
Diabetes Research and Clinical Practice, accepted. (2.741)
11.
Wang Y, Tuomilehto J, Jousilahti P, Antikainen R, Mähönen M, Katzmarzyk PT, Hu G. Healthy
Lifestyle Status and Antihypertensive Treatment and the Risk of Heart Failure among Finnish Men and
Women. Journal of Hypertension, accepted. (3.806)
12.
Zhao W, Katzmarzyk PT, Horswell R, Wang Y, Johnson J, Cefalu WT, Ryan DH, Hu G. Blood
pressure and stroke risk among diabetic patients. The Journal of Clinical Endocrinology & Metabolism,
accepted. (6.43)
13.
Zhao W, Katzmarzyk PT, Horswell R, Wang Y, Li W, Johnson J, Heymsfield SB, Cefalu WT, Ryan DH,
Hu G. Aggressive blood pressure control increases coronary heart disease risk among diabetic
patients. Diabetes Care, accepted. (7.735).
14.
Zhao W, Katzmarzyk PT, Horswell R, Wang Y, Johnson J, Heymsfield SB, Cefalu WT, Ryan DH, Hu
G. HbA1c and lower extremity amputation risk in low-income the diabetic patients. Diabetes Care,
accepted. (7.735).
15.
Bidel S, Hu G, Jousilahti P, Pukkala E, Hakulinen T, Tuomilehto J. Coffee consumption and risk of
gastric and pancreatic cancer - A prospective cohort study. International Journal of Cancer 2013; 132:
1651-1659. (6.198)
16.
Hu G, Cui Y, Jousilahti P, Sundvall J, Girman CJ, Antikainen R, Laatikainen T, Tuomilehto J. Joint
effect of high-density lipoprotein cholesterol and low-density lipoprotein cholesterol on the risk of
coronary heart disease. European Journal of Preventive Cardiology 2013; 20: 89-97. (2.634)
17.
Shi Z, Wittert GA Yuan B, Dai Y, Gill TK, Hu G, Adams R, Zuo H, Taylor AW. Association between
monosodium glutamate intake and sleep-disordered breathing among Chinese adults with normal
body weight. Nutrition 2013; 29: 508-513. (2.859)
18.
Wang Y, Tuomilehto J, Jousilahti P, Salomaa V, Li B, Antikainen R, Mähönen M, Katzmarzyk PT, Hu
G. Serum γ-glutamyltransferase and the risk of heart failure in men and women in Finland. Heart 2013;
99: 163-167. (5.014)
19.
Hu G, Horswell R, Wang Y, Li W, Besse J, Xiao K, Chen H, Keller JN, Heymsfield SB, Ryan DH,
Katzmarzyk PT. Body mass index and the risk of dementia among Louisiana low income diabetic
patients. PLoS One 2012; 7: e44537. (3.73)
20.
Hu G, Tian HG, Zhang F, Liu H, Zhang CP, Zhang S, Liu G, Yu Z, Yang X, Qi L, Zhang Cl, Wang H, Li
M, Leng J, Li Y, Wang L, Dong L, Tuomilehto J. Tianjin Gestational Diabetes Mellitus Prevention
Program: Study design, methods, and 1-year interim report on the feasibility of lifestyle intervention
program. Diabetes Research and Clinical Practice 2012; 98: 508-517. (2.741)
21.
Shi Z, Taylor AW, Hu G, Gill T, Wittert G. Rice intake, weight change and risk of metabolic syndrome
development among Chinese adults: the Jiangsu Nutrition Study (JIN). Asia Pacific Journal of Clinical
Nutrition 2012; 21: 35-43. (1.055)
22.
Wang Y, Chen L, Horswell R, Xiao K, Besse J, Johnson J, Ryan DH, Hu G. Racial differences in the
association between gestational diabetes mellitus and risk of type 2 diabetes. Journal of Women’s
Health 2012; 21; 628-633. (1.417)
23.
Wang Y, Chen L, Xiao K, Horswell R, Besse J, Johnson J, Ryan DH, Hu G. Increasing prevalence of
gestational diabetes mellitus in Louisiana, 1997-2009. Journal of Women’s Health 2012; 21: 319-325.
(1.417)
24.
Wang Y, Katzmarzyk PT, Horswell R, Li W, Xiao K, Besse J, Xie W, Johnson J, Heymsfield S, Ryan
DH, Hu G. Racial Disparities in Diabetic Complications in an Underinsured Population. The Journal of
Clinical Endocrinology & Metabolism 2012; 97: 4446-4453. (6.43)
25.
Zhang Y, Hu G. Dietary pattern, lifestyle factors and cardiovascular diseases. Current Nutrition
Reports 2012; 1: 64-72.
26.
Zhang Y, Hu G. Lifestyle factors, antihypertensive treatment and stroke risk (review). Chinese Journal
of Hypertension 2012; 20: 1004-1007 (in Chinese).
27.
Zhang Y, Hu G, Yuan Z, Chen L. Glycosylated hemoglobin in relationship to cardiovascular outcomes
and death in patients with type 2 diabetes: A systematic review and meta-analysis. PLoS One 2012;
7(8): e42551. (3.73)
28.
Zhang Y, Li W, Wang Y, Chen L, Horswell R, Xiao K, Besse J, Johnson J, Ryan DH, Hu G. Increasing
prevalence of hypertension in low income residents within Louisiana State University Health Care
Services Division Hospital System. European Journal of Internal Medicine 2012; 23: e179-e184.
(2.045)
29.
Zhang Y, Tuomilehto J, Jousilahti P, Wang Y, Antikainen R, Hu G. Lifestyle factors and
antihypertensive treatment on the risks of stroke and its subtype. Hypertension 2012; 60: 906-912.
(6.873)
30.
Zhang Y, Tuomilehto J, Jousilahti P, Wang Y, Antikainen R, Hu G. Serum total and high-density
lipoprotein cholesterol and the risk of total and type-specific stroke. Stroke 2012; 43: 1768-1774.
(5.158)
31.
Zuo H, Shi Z, Yuan B, Dai Y, Hu G, Wu G, Hussain A. Interaction between physical activity and sleep
duration in relation to insulin resistance among non-diabetic Chinese adults. BMC Public Health 2012;
12:247. (2.076)
32.
Bowers K, Liu G, Wang P, Ye T, Tian Z, Liu E, Yu Z, Yang X, Klebanoff M, Yeung E, Hu G, Zhang C.
Birth weight, postnatal weight change, and risk for high blood pressure among Chinese children aged
3-6 years. Pediatrics 2011; 127: E1272-1279. (5.119)
33.
Hu G. Bouchard C, Bray GA, Greenway FL, Johnson WD, Newton Jr RL, Ravussin E, Ryan D,
Katzmarzyk PT. Trunk versus extremity fat and cardiometabolic risk factors in white and African
American adults. Diabetes Care 2011:34: 1415-1418. (7.735).
34.
Li W, Wang Y, Chen L, Horswell R, Xiao K, Besse J, Johnson J, Ryan DH, Hu G. Increasing
prevalence of diabetes in Louisiana from 2000 to 2009. Diabetes Research and Clinical Practice 2011;
94: 262-268. (2.741)
35.
Qiu C*, Hu G*, Kivipelto M, Laatikainen T, Antikainen R, Fratiglioni L, Jousilahti P, Tuomilehto J.
Hypertension and the risk of Parkinson’s disease: National FINRISK Study. Hypertension 2011; 57:
1094-1100. (6.873) (*Co-first author)
36.
Shi Z, Yuan BJ, Hu G, Dai Y, Zuo H, Holmboe-Ottesen G. Dietary pattern and weight change in a 5
year follow up among Chinese adults: Results from Jiangsu Nutrition and Health Study. British Journal
of Nutrition 2011; 105: 1047-1054. (3.302)
37.
Wang Y, Hu G. The effects of coffee consumption on the risk of heart failure. North American Journal
of Medicine and Science 2011; 4; 183-186.
38.
Wang Y, Tuomilehto J, Jousilahti P, Antikainen R, Mähönen M, Katzmarzyk PT, Hu G. Lifestyle
Factors in Relation to Heart Failure among Finnish Men and Women. Circulation: Heart Failure 2011;
4: 607-612. (6.684)
39.
Wang Y, Tuomilehto J, Jousilahti P, Antikainen R, Mähönen M, Katzmarzyk PT, Hu G. Coffee
consumption and the risk of heart failure. Heart 2011; 97: 44-48. (5.014)
40.
Zhang FX, Dong L, Zhang CP, Li BJ, Wen J, Gao W, Sun SR, Lv FJ, Tian HG, Tuomilehto J, Qi L,
Zhang CL, Yu ZJ, Yang XL, Hu G. Increasing prevalence of gestational diabetes mellitus in Chinese
women from 1999 to 2008. Diabetic Medicine 2011; 28: 652-657. (3.241)
41.
Zhang Y, Chen L, Hu G. Physical activity and hypertension: results from cohort studies and metaanalysis. Journal of Education Research 2011; 5: 39-58.
42.
Zhang Y, Tuomilehto J, Jousilahti P, Wang Y, Antikainen R, Hu G. Lifestyle Factors on the Risks of
Ischemic and Hemorrhagic Stroke. Archive of Internal Medicine 2011; 171: 1811-1818. (11.462)
43.
Zhang Z, Hu G, Caballero B, Appel L, Chen L. Habitual Coffee Consumption and Risk of
Hypertension: A Meta-Analysis of Prospective Studies. American Journal of Clinical Nutrition 2011; 93:
1212-1219. (6.504)
44.
Bidel S, Hu G, Jousilahti P, Antikainen R, Pukkala E, Hakulinen T, Tuomilehto J. Coffee Consumption
and Risk of Colorectal Cancer. European Journal of Clinical Nutrition 2010; 64: 917-923. (2.756)
45.
Hu G. Total cholesterol and the risk of Parkinson’s disease: a review for some new findings.
Parkinson's Disease Volume 2010, Article ID 836962, 6 pages.
46.
Hu G, Jousilahti P, Antikainen R, Katzmarzyk PT, Tuomilehto J. Joint effects of physical activity, body
mass index, waist circumference and waist-hip ratio with the risk of heart failure. Circulation 2010; 121:
237-244. (15.202)
47.
Shi Z, Hu X, Yuan B, Hu G, Pan X, Dai Y, Holmboe-Ottesen G, Byles J. Association between food
pattern and metabolic syndrome in China. Journal of Diabetology 2010; 2: 3 (1-12).
48.
Tian Z, Ye T, Zhang XY, Liu EQ, Wang W, Wang P, Liu GS, Yang XL, Hu G, Yu ZJ. Sleep duration
and hyperglycaemia among obese and non-obese children aged 3 to 6 years. Archives of Pediatrics &
Adolescent Medicine 2010; 164: 46-52. (4.282).
49.
Wang Y, Hu G. The individual and joint associations of obesity and physical activity on the risk of
heart failure. Congestive Heart Failure 2010; 16: 292-299.
50.
Wang Y, Tuomilehto J, Jousilahti P, Antikainen R, Mähönen M, Katzmarzyk PT, Hu G. Occupational,
commuting and leisure-time physical activity in relation to heart failure among Finnish men and
women. Journal of the American College of Cardiology 2010; 56: 1140-1148. (14.086).
51.
Barengo NC, Hu G, Kastarinen M, Antikainen R, Tuomilehto J. The effects of awareness, treatment
and control of hypertension on future stroke incidence in a community-based population study in
Finland. Journal of Hypertension 2009; 27: 1459-1465. (3.806)
52.
Du X, Zhu BL, Hu G, Mao WG, Wang SQ, Zhang H, Wang F, Shi ZM. U-shape association between
white blood cell count and the risk of diabetes in young Chinese adults. Diabetic Medicine 2009; 26:
955-960. (3.241)
53.
Hu G. Vascular risk factors and the risk of Parkinson’s disease: some new findings. North American
Journal of Medicine and Science 2009; 2: 102-105.
54.
Hu G, Jousilahti, P, Tuomilehto J, Antikainen R, Sundvall J Salomaa V. Association of serum Creactive protein level with sex-specific type 2 diabetes risk: a prospective Finnish study. The Journal of
Clinical Endocrinology & Metabolism 2009; 94: 2099-2105. (6.43)
55.
Khalangot M, Hu G, Tronko M, Kravchenko V, Guryanov V. Gender risk of non-fatal stroke in type 2
diabetic patients differs depending on the type of treatment. Journal of Women’s Health 2009; 18: 97103 (1.417).
56.
Khalangot M, Tronko M, Kravchenko V, Culchinska J, Hu G. Body mass index and the risk of total and
cardiovascular mortality among patients with type 2 diabetes: a large prospective study in Ukraine.
Heart 2009; 95: 454-460. (5.014)
57.
Tian HG, Song GD, Xie HX, Zhang H, Tuomilehto J, Hu G. Prevalence of diabetes and impaired
fasting glucose among 767,160 rural Chinese adults. Diabetes Research and Clinical Practice 2009;
84: 273-278. (2.741)
58.
Tian HG, Xie HX, Song GD, Zhang H, Hu G. Prevalence of overweight and obesity among 2.6 million
rural Chinese adults. Preventive Medicine 2009; 48: 59-63. (3.496)
59.
Zhang XY, Liu EQ, Tian Z, Wang W, Ye T, Liu GS, Li YM, Wang P, Yang XL, Yu ZJ, Hu G. High birth
weight and overweight or obesity among Chinese children 3-6 years old. Preventive Medicine 2009;
49:172-178. (3.496)
60.
Bidel S, Hu G, Tuomilehto J. Coffee consumption and type 2 diabetes – an extensive review. Central
European Journal of Medicine 2008; 3: 9-19. (0.262)
61.
Bidel S, Silventoinen K, Hu G, Lee DH, Kaprio J, Tuomilehto J. Coffee consumption, serum gammaglutamyltransferase and risk of type 2 diabetes. European Journal of Clinical Nutrition 2008; 62: 178185. (2.756)
62.
Hu G, Antikainen R, Jousilathi P, Kivipelto M, Tuomilehto J. Total cholesterol and the risk of Parkinson
disease. Neurology 2008; 70: 1972-1979. (8.249).
63.
Hu G, Lindström J, Jousilahti P, Peltonen M, Sjöberg L, Kaaja R, Sundvall J, Tuomilehto J. The
increasing prevalence of metabolic syndrome among Finnish men and women over a decade. The
Journal of Clinical Endocrinology & Metabolism 2008; 93: 832-836. (6.43)
64.
Hu G, Tuomilehto J, Pukkala E, Hakulinen T, Antikainen R, Vartiainen E, Jousilahti P. Joint effects of
coffee consumption and serum gamma-glutamyltransferase on the risk of liver cancer. Hepatology
2008; 48: 129-136. (12.003)
65.
Khalangot M, Tronko M, Kravchenko V, Kulchinska J, Hu G. The joint effects of different types of
glucose-lowering treatment and duration of diabetes on total and cardiovascular mortality among
subjects with type 2 diabetes. Diabetes Research and Clinical Practice 2008; 82: 139-147. (2.741)
66.
Qi L, Hu, FB, Hu G. Genetic, exercise and prevention of type 2 diabetes. Current Molecular Medicine
2008; 8: 519-532. (4.197)
67.
Shi ZM, Hu XS, Yuan BJ, Hu G, Pan XQ, Byles JE, Holmboe-Ottesen G. Vegetable-rich food pattern
is related to obesity in China. International Journal of Obesity 2008; 32: 975-984. (5.221)
68.
Shi ZM, Hu XS, Yuan BJ, Hu G, Pan XQ, Holmboe-Ottesen G. Coexistence of anaemia and the
metabolic syndrome in adults in Jiangsu, China. Asia Pacific Journal of Clinical Nutrition 2008; 17:
505-513. (1.055)
69.
Barengo NC, Hu G, Tuomilehto J. Physical activity and hypertension: evidence of cross-sectional
studies, cohort studies and meta-analysis. Current Hypertension Reviews 2007; 3: 255-263.
70.
Hu G, Bidel S, Jousilahti P, Antikainen R, Tuomilehto J. Coffee and tea consumption and the risk of
Parkinson’s disease. Movement Disorders 2007; 22: 2242-2248. (>50 citations) (4.558)
71.
Hu G, Jousilahti P, Antikainen R, Tuomilehto J. Occupational, commuting, and leisure-time physical
activity in relation to cardiovascular mortality among Finnish subjects with high blood pressure.
American Journal of Hypertension 2007; 20: 1242-1250. (3.665)
72.
Hu G, Jousilahti P, Bidel S, Antikainen R, Tuomilehto J. Type 2 diabetes and the risk of Parkinson’s
disease. Diabetes Care 2007; 30: 842-847. (>60 citations) (7.735)
73.
Hu G, Jousilahti P, Borodulin K, Barengo NC, Lakka TA, Nissinen A, Tuomilehto J. Occupational,
commuting, and leisure-time physical activity in relation to coronary heart disease among middle-aged
Finnish men and women. Atherosclerosis 2007; 194: 490-497. (3.706)
74.
Hu G, Jousilahti P, Nissinen A, Bidel S, Antikainen R, Tuomilehto J. Coffee consumption and the
incidence of antihypertensive drug treatment in Finnish men and women. American Journal of Clinical
Nutrition 2007; 86: 457-464. (6.504)
75.
Hu G, Jousilathi P, Tuomilehto J. Joint effects of history of hypertension at baseline and type 2
diabetes at baseline and during follow-up on the risk of coronary heart disease. European Heart
Journal 2007; 28: 3059-3066. (14.097)
76.
Hu G, Lakka TA, Kilpelainen TO, Tuomilehto J. Epidemiological studies of exercise in diabetes
prevention. Applied Physiology, Nutrition, and Metabolism 2007; 32; 583-595. (2.009)
77.
Hu G, Tuomilehto J, Borodulin K, Jousilahti P. The joint associations of occupational, commuting, and
leisure-time physical activity, and the Framingham risk score on the 10-year risk of coronary heart
disease. European Heart Journal 2007; 28: 492-498. (14.097)
78.
Hu G, Tuomilehto J, Silventoinen K, Sarti C, Männistö S, Jousilahti P. Body mass index, waist
circumference and waist-hip ratio on the risk of total and type-specific stroke. Archive of Internal
Medicine 2007; 167: 1420-1427. (>60 citations) (11.462)
79.
Wang JJ, Li HB, Kinnunen L, Hu G, Järvinen TM, Miettinen ME, Yuan SY, Tuomilehto J. How well
does the metabolic syndrome defined by five definitions predict incident diabetes and incident
coronary heart disease in a Chinese population? Atherosclerosis 2007; 192: 161-168. (3.706)
80.
Bidel S, Hu G, Sundvall J, Kaprio J, Tuomilehto J. Effects of coffee consumption on glucose tolerance,
serum glucose and insulin levels – a cross-sectional analysis. Hormone and Metabolic Research
2006; 38: 38-43. (2.145)
81.
Bidel S*, Hu G*, Qiao Q, Jousilahti P, Antikainen R, Tuomilehto J. Coffee consumption and risk of total
and cardiovascular mortality among patients with type 2 diabetes. Diabetologia 2006; 49: 2618-2626.
(6.487) (*Co-first author)
82.
Hu G, Jousilahti P, Nissinen A, Antikainen R, Kivipelto M, Tuomilehto J. Body mass index and the risk
of Parkinson’s disease. Neurology 2006; 67: 1955-1959. (>50 citations) (8.249)
83.
Hu G, Jousilahti P, Peltonen M, Bidel S, Tuomilehto J. Joint association of coffee consumption and
other factors to the risk of type 2 diabetes: a prospective study in Finland. International Journal of
Obesity 2006; 30: 1742-1749. (5.221)
84.
Hu G, Jousilahti P, Sarti C, Antikainen R, Tuomilehto J. The effect of diabetes and stroke at baseline
and during follow-up on stroke mortality. Diabetologia 2006; 49: 2309-2316. (6.487)
85.
Hu G, Lakka TA, Lakka HM, Tuomilehto J. Lifestyle management in the Metabolic Syndrome.
Metabolic Syndrome and Related Disorders 2006; 4: 270-286. (1.652)
86.
Hu G, Rico-Sanz J, Lakka TA, Tuomilehto J. Exercise, genetics and prevention of type 2 diabetes.
Essays in Biochemistry 2006; 42: 177-192. (3.468)
87.
Lee DH, Silventoinen K, Hu G, Jacobs Jr DR, Jousilahti P, Tuomilehto J. Serum gammaglutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among
28838 middle-aged men and women. European Heart Journal 2006; 27: 2170-2176. (>80 citations)
(14.097)
88.
Nakagami T, Qiao Q, Tuomilehto J, Balkau B, Tajima N, Hu G, Borch-Johnsen K for the DECODA
Study Group. Screen-detected diabetes, hypertension and hypercholesteremia as predictors of
cardiovascular mortality in five populations of Asian origin: the DECODA study. European Journal of
Cardiovascular Prevention and Rehabilitation 2006; 13: 555-561. (2.634)
89.
Barengo NC, Hu G, Kastarinen M, Lakka TA, Pekkarinen H, Nissinen A, Tuomilehto J. Low physical
activity as a predictor for antihypertension drug treatment in 25-64-years-old populations in Eastern
and South-West Finland. Journal of Hypertension 2005; 23: 293-299. (3.806)
90.
Hu G, Jousilahti P, Barengo NC, Qiao Q, Lakka TA, Tuomilehto J. Physical activity, cardiovascular
risk factors, and mortality among Finnish adults with diabetes. Diabetes Care 2005; 28: 799-805. (>60
citations) (7.735)
91.
Hu G, Jousilahti P, Qiao Q, Katoh S, Tuomilehto J. Sex differences in cardiovascular and total
mortality among diabetic and non-diabetic individuals with or without history of myocardial infarction.
Diabetologia 2005; 48: 856-861. (6.487)
92.
Hu G, Jousilahti P, Qiao Q, Peltonen M, Katoh S, Tuomilehto J. The gender-specific impact of
diabetes and myocardial infarction at baseline and during follow-up on mortality from all causes and
coronary heart disease. Journal of the American College of Cardiology 2005; 45: 1413-1418. (14.086)
93.
Hu G, Jousilahti P, Peltonen M, Lindström J, Tuomilehto J. Urinary sodium and potassium excretion
and the risk of type 2 diabetes: a prospective study in Finland. Diabetologia 2005; 48: 1477-1483.
(6.487)
94.
Hu G, Lakka TA, Barengo NC, Tuomilehto J. Physical activity, physical fitness and the risk of type 2
diabetes. Metabolic Syndrome and Related Disorders 2005; 3: 35-44. (1.652)
95.
Hu G, Qiao Q, Tuomilehto J. The metabolic syndrome and cardiovascular risk. Current Diabetes
Reviews 2005; 1: 137-144.
96.
Hu G, Sarti C, Jousilahti P, Peltonen M, Qiao Q, Antikainen R, Tuomilehto J. The impact of history of
hypertension and type 2 diabetes at baseline on the incidence of stroke and stroke mortality. Stroke
2005; 36: 2538-2543. (6.158)
97.
Hu G, Sarti C, Jousilahti P, Silventoinen K, Barengo NC, Tuomilehto J. Leisure time, occupational,
and commuting physical activity and the risk of stroke. Stroke 2005; 36: 1994-1999. (>100 citations)
(6.158)
98.
Hu G, Tuomilehto J, Silventoinen K, Barengo NC, Peltonen M, Jousilahti P. The effects of physical
activity and body mass index on cardiovascular, cancer and all-cause mortality among 47212 middleaged Finnish men and women. International Journal of Obesity 2005; 29: 894-902. (>120 citations)
(5.221)
99.
Patja K, Jousilahti P, Hu G, Valle TT, Qiao Q, Tuomilehto J. Effects of smoking, obesity and physical
activity on the risk of type 2 diabetes in middle-aged Finnish men and women. Journal of Internal
Medicine 2005; 258: 356-362. (6.455)
100. Qiao Q, Pyörälä K, Tuomilehto J, Gao WG, Hu G, Peltonen M, Dekker JM, Alberti KGMM for the
DECODE Study Group. Comparison of three different definitions for the metabolic syndrome in nondiabetic Europeans. The British Journal of Diabetes & Vascular Disease 2005; 5: 161-168.
101. Silventoinen K, Pankow J, Jousilahti P, Hu G, Tuomilehto J. Educational inequalities in the metabolic
syndrome and coronary heart disease among middle-aged men and women. International Journal of
Epidemiology 2005; 34: 327-334. (6.982)
102. Silventoinen K, Pankow J, Lindström J, Jousilahti P, Hu G, Tuomilehto J. The validity of the Finnish
Diabetes Risk Score for prediction of the incidence of coronary heart disease and stroke, and total
mortality. European Journal of Cardiovascular Prevention and Rehabilitation 2005; 12: 451-458.
(2.634)
103. Wang JJ, Hu G, Lappalainen J, Miettinen ME, Qiao Q, Tuomilehto J. Changes in features of the
metabolic syndrome and incident impaired glucose regulation or type 2 diabetes in a Chinese
population. Diabetes Care 2005; 28: 448-450. (7.735)
104. Balkau B, Hu G, Qiao Q, Tuomilehto J, Borch-Johnsen K, Pyörälä K for the DECODE Study Group.
Prediction of the risk of cardiovascular mortality using a score that includes glucose as a risk factor.
The DECODE Study. Diabetologia 2004; 47: 2118-2128. (>50 citations) (6.487)
105. Barengo NC, Hu G, Lakka TA, Pekkarinen H, Nissinen A, Tuomilehto J. Low physical activity as a
predictor for total and cardiovascular disease mortality in middle-aged men and women in Finland.
European Heart Journal 2004; 25: 2204-2211. (>100 citations) (14.097)
106. Hu G, Barengo NC, Tuomilehto J, Lakka TA, Nissinen A, Jousilahti P. Relationship of physical activity
and body mass index to the risk of hypertension: a prospective study in Finland. Hypertension 2004;
43: 25-30. (>100 citations) (6.873)
107. Hu G, Eriksson JG, Barengo NC, Lakka TA, Valle TT, Nissinen A, Jousilahti P, Tuomilehto J.
Occupational, commuting, and leisure-time physical activity in relation to total and cardiovascular
mortality among Finnish subjects with type 2 diabetes. Circulation 2004; 110: 666-673. (>90 citations)
(15.202)
108. Hu G, Lakka TA, Barengo NC, Tuomilehto J. Physical activity in the prevention of type 2 diabetes.
Cardiovascular Medicine (Office Journal of the Swiss Society of Angiology, the Swiss Society of
Endocrinology & Diabetology as well as the Swiss Hypertension Society) 2004; 7: 394-405.
109. Hu G, Lindström J, Valle TT, Eriksson JG, Jousilahti P, Silventoinen K, Qiao Q, Tuomilehto J. Physical
activity, body mass index, and risk of type 2 diabetes in patients with normal and impaired glucose
regulation. Archive of Internal Medicine 2004; 164: 892-896. (>130 citations) (11.462)
110. Hu G, Qiao Q, Tuomilehto J. The metabolic syndrome and cardiovascular risk: is it different between
men and women. XX vs. XY 2004; 2: 15-20.
111. Hu G, Qiao Q, Tuomilehto J. Balkau B, Borch-Johnsen K, Pyörälä K for the DECODE Study Group.
Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in
nondiabetic European men and women. Archive of Internal Medicine 2004; 164: 1066-1076. (>460
citations) (11.462)
112. Hu G, Qiao Q, Tuomilehto J, Eliasson M, Feskens E, Pyörälä K for the DECODE Study Group.
Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a metaanalysis of data from eleven prospective studies. Diabetologia 2004; 47: 1245-1256. (>50 citations)
(6.487)
113. Hu G, Tuomilehto J, Silventoinen K, Barengo NC, Jousilahti P. Joint effects of physical activity, body
mass index, waist circumference and waist-to-hip ratio with the risk of cardiovascular disease among
middle-aged Finnish men and women. European Heart Journal 2004; 25: 2212-2219. (>100 citations)
(14.097)
114. Nakagami T, Qiao Q, Tuomilehto J, Balkau B, Tajima N, Hu G, Borch-Johnsen K for the DECODA
Study Group. Hyperglycaemia and mortality from all causes and from cardiovascular disease in five
populations of Asian origin. Diabetologia 2004; 47: 385-394. (>100 citations) (6.487)
115. Sarlio-Lähteenkorva S, Silventoinen K, Jousilahti P, Hu G, Tuomilehto J. The association between
thinness and socio-economic disadvantage, health indicators, and adverse health behaviour: a study
of 28000 Finnish men and women. International Journal of Obesity and Related Metabolic Disorders
2004; 28: 568-573. (5.221)
116. Tuomilehto J, Hu G, Bidel S, Lindström J, Jousilahti P. Coffee consumption and risk of type 2 diabetes
mellitus among middle-aged Finnish men and women. The Journal of the American Medical
Association (JAMA) 2004; 291: 1213-1219. (>130 citations) (29.978)
117. Wang JJ, Hu G, Miettinen ME, Tuomilehto J. The metabolic syndrome and incident diabetes:
Assessment of four suggested definitions of the metabolic syndrome in a Chinese population with high
post-prandial glucose. Hormone and Metabolic Research 2004; 36: 708-715. (2.145)
118. Wang JJ, Qiao Q, Miettinen ME, Lappalainen J, Hu G, Tuomilehto J. The metabolic syndrome defined
by factor analysis and incident type 2 diabetes in a Chinese population with high postprandial glucose.
Diabetes Care 2004; 47: 2429-2437. (7.735)
119. Wang JJ, Yuan SY, Zhu LX, Fu HJ, Li HB, Hu G, Tuomilehto J. Effects of impaired fasting glucose
and impaired glucose tolerance on predicting incident type 2 diabetes in a Chinese population with
high post-prandial glucose. Diabetes Research and Clinical Practice 2004; 66: 183-191. (2.741)
120. Hu G, Qiao Q, Silventoinen K, Eriksson JG, Jousilahti P, Lindström J, Valle TT, Nissinen A,
Tuomilehto J. Occupational, commuting, leisure-time physical activity in relation to risk for type 2
diabetes in middle-aged Finnish men and women. Diabetologia 2003; 46: 322-329. (>130 citations)
(6.487)
121. Hu G, Qiao Q, Tuomilehto J. Balkau B, Borch-Johnsen K for the DECODE Study Group. Gender
difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed
diabetes. Diabetologia 2003; 46: 608-617. (>80 citations) (6.487)
122. Hu G, Tuomilehto J. Coffee, tea and their impact on the risk of diabetes. International Diabetes
Monitor 2003; 15 (6): 1-5.
123. Nakagami T, Qiao Q, Carstensen B, Nøhr-Hansen C, Hu G, Tuomilehto J, Balkau B, Borch-Johnsen K
for the DECODE-DECODA Study Group. Age, body mass index and type 2 diabetes – associations
modified by ethnicity. Diabetologia 2003; 46: 1063-1070. (>60 citations) (6.476)
124. Qiao Q, Hu G, Tuomilehto J. Eriksson JG, Balkau B, Borch-Johnsen K for the DECODE Study Group.
Age- and sex-specific prevalence of diabetes and impaired glucose regulation in 13 European cohorts.
Diabetes Care 2003; 26: 61-69. (>190 citations) (7.735)
125. Qiao Q, Hu G, Tuomilehto J, Nakagami T, Balkau B, Borch-Johnsen K, Ramachandran A, Mohan V,
Iyer SR, Tominaga M, Kiyohara Y, Kato I, Okubo K, Nagai M, Shibazaki S, Yang Z, Tong Z, Fan Q,
Wang B, Chew SK, Tan BY, Heng D, Emmanuel S, Tajima N, Iwamoto Y, Snehalatha C, Vijay V,
Kapur A, Dong Y, Nan H, Gao W, Shi H, Fu F for the DECODA Study Group. Age- and sex-specific
prevalence of diabetes and impaired glucose regulation in 11 Asian cohorts. Diabetes Care 2003; 26:
1770-1780. (>100 citations) (7.735)
126. Tuomilehto J, Hu G. Physical fitness and risk factors for cardiovascular disease and type 2 diabetes.
International Diabetes Monitor 2003; 15 (2): 5-7.
127. Hu G, Pekkarinen H, Hänninen O, Tian HG, Jin RP. Comparison of dietary and non-dietary risk factors
in overweight and normal-weight Chinese adults. British Journal of Nutrition 2002; 88: 91-97. (3.302)
128. Hu G, Pekkarinen H, Hänninen O, Yu ZJ, Guo ZY, Tian HG. Commuting, leisure-time physical activity,
and cardiovascular risk factors in China. Medicine and Science in Sports and Exercise 2002; 34: 234238. (>50 citations) (4.475)
129. Hu G, Pekkarinen H, Hänninen O, Yu ZJ, Tian HG, Guo ZY, Nissinen A. Physical activity during
leisure and commuting in Tianjin, China. Bulletin of the World Health Organization 2002; 80: 933-938.
(5.25)
130. Hu G, Qiao Q, Tuomilehto J. Non-hypertensive cardiac effects of a high salt diet. Current
Hypertension Reports 2002; 4: 13-17. (3.744)
131. Yu ZJ, Nissinen A, Vartiainen E, Hu G, Tian HG, Guo ZY. Socioeconomic status and serum lipids: A
cross-sectional study in a Chinese urban population. Journal of Clinical Epidemiology 2002; 55: 143149. (5.332)
132. Hu G, Pekkarinen H, Halonen P, Hänninen O, Tian HG, Guo ZY, Kumpusalo E. Different worlds,
different tasks for health promotion: comparisons of health risk profiles in Chinese and Finnish rural
people. Health Promotion International 2001; 16: 315-320. (1.377)
133. Hu G, Pekkarinen H, Hänninen O, Tian HG, Guo ZY. Relation between commuting, leisure time
physical activity and serum lipids in a Chinese urban population. Annals of Human Biology 2001; 28:
412-421. (1.484)
134. Hu G, Qiao Q, Tuomilehto J. Glucose tolerance and cardiovascular mortality. Cardiovascular Reviews
& Reports 2001; 22: 649-654&692.
135. Hu G, Tian HG. A comparison of dietary and non-dietary factors of hypertension and normal blood
pressure in a Chinese population. Journal of Human Hypertension 2001; 15: 487-493. (2.818)
136. Yang XL, Hsu-Hage BH-H, Tian HG, Hu G, Dong QN, Wu JH, Wahlqvist ML. The role of income and
education in food consumption and nutrient intake in a Chinese population. Asia Pacific Journal of
Clinical Nutrition 1998; 7: 217-223. (1.055)
137. Tian HG, Hu G, Nan Y, Shao RC, Gong QN. Relationship between serum lipids and dietary and nondietary factors in a Chinese population. Chinese Journal of Prevention and Control Non-communicable
Diseases 1997; 6: 304-310 (in Chinese).
138. Tian HG, Hu G, Dong QN, Yang XL, Nan Y, Pietinen P, Nissinen A. Dietary sodium and potassium,
socioeconomic status and blood pressure in a Chinese population. Appetite 1996; 26: 235-246.
(2.541)
139. Tian HG, Nan Y, Hu G, Dong QN, Yang XL. A dietary survey of the Chinese population in urban and
rural areas of Tianjin. Asia Pacific Journal of Clinical Nutrition 1996; 5: 229-232. (1.055)
140. Tian HG, Hu G, Nan Y, Shao RC, Gong QN. Association between blood pressure and dietary intake
and urinary excretion of sodium, potassium, calcium and magnesium in Tianjin. Chinese Journal of
Prevention and Control Non-communicable Diseases 1996; 4: 203-208 (in Chinese).
141. Wang X, Yang XL, Hu G, Dong QN, Nan Y, Tian HG. Assessment of dietary consumption in Tianjin in
1992. Chinese Journal of Prevention and Control Non-communicable Diseases 1996; 1: 18-21 (in
Chinese).
142. Hu G, Yu ZJ, Tian HG. Effect of nutrition intervention of low sodium salt intake in the NCD intervention
area. Chinese Journal of Prevention and Control Non-communicable Diseases 1995; 3: 131-133 (in
Chinese).
143. Nan Y, Tian HG, Shao RC, Hu G, Dong QN, Pietinen P, Nissinen A. Assessment of sodium and
potassium in processed foods in an urban area in China. European Journal of Clinical Nutrition 1995;
49: 299-306. (2.756)
144. Tian HG, Guo ZY, Hu G, Yu ZJ, Sun W, Pietinen P, Nissinen A. Change in sodium intake and blood
pressure in a community-based intervention project in China. Journal of Human Hypertension 1995; 9:
959-968. (2.818)
145. Tian HG, Nan Y, Hu G, Dong QN, Yang XL, Pietinen P, Nissinen A. Dietary survey in a Chinese
population. European Journal of Clinical Nutrition 1995; 49: 26-32. (2.756)
146. Tian HG, Nan Y, Hu G, Shao RC, Gong QN. Assessment of sodium and potassium in children dietary
in child-care center. Chinese Journal of Prevention and Control Non-communicable Diseases 1995; 6:
270-275 (in Chinese).
147. Tian HG, Nan Y, Shao RC, Gong QN, Hu G, Pietinen P, Nissinen A. Associations between blood
pressure and dietary intake and urinary excretion of electrolytes in a Chinese population. Journal of
Hypertension 1995; 13: 49-56. (3.806)
148. Yu ZJ, Nan Y, Hu G, Yang XL, Dong QN, Shao RC, Bao J, Wu JH, Jia M. Difference in salt intake of
inhabitants in treatment and control communities of the Tianjin NCD Project. Chinese Journal of
Prevention and Control Non-communicable Diseases 1995; 4: 166-168 (in Chinese).
149. Tian HG, Sun W, Yu ZJ, Hu G. Evaluation of dietary pattern in inhabitants of Tianjin. Chinese Journal
of Prevention and Control Non-communicable Diseases 1993; 2: 22-25 (in Chinese).
Letters in Peer-reviewed Journals (impact factors)
150. Wang Y, Hu G. Is hepatic congestion a risk factor for cholangitis in heart failure patients with coexisting choledocholithiais? – The Response. Heart 2013; 99: 1216. (5.014)
151. Hu G, Antikainen R, Jousilathi P, Kivipelto M, Tuomilehto J. Total cholesterol and the risk of
Parkinson’s disease-reply. Neurology 2009; 72: 860-861. (8.249).
152. Hu G, Tuomilehto J, Silventoinen K, Jousilahti P. Waist to hip ratio as a supplement to body mass
index- reply. Archive of Internal Medicine 2008; 168: 238-238. (11.462)
153. Hu G, Jousilahti P, Tuomilehto J. Body mass index and the risk of Parkinson disease-reply.
Neurology 2007; 68: 2156-2157. (8.249)
154. Hu G, Jousilahti P, Tuomilehto J. Prevalence of nonalcoholic Fatty liver disease and its association
with cardiovascular disease among type 2 diabetic patients: response to Talim. Diabetes Care 2007;
30: e56-e56. (7.735)
155. Hu G, Jousilahti P, Tuomilehto J. Obstructive sleep apnea as an independent risk factor for stroke and
mortality-Reply. Stroke 2006; 37:1150. (6.158)
156. Patja K, Jousilahti P, Hu G, Valle TT, Qiao Q, Tuomilehto J. Tobacco smoke, systemic inflammation
and the risk of type 2 diabetes-Reply. Journal of Internal Medicine 2006; 259: 333. (6.455)
Book-chapters
157. Hu G. Diabetes mellitus, Prevention. In: Mooren FC ed. Encyclopedia of Exercise Medicine in Health
and Disease. Springer 2012: 243-245.
158. Hu G, Lakka TA, Tuomilehto J. Metabolic Syndrome. In: Mooren FC ed. Encyclopedia of Exercise
Medicine in Health and Disease. Springer 2012: 566-569.
159. Yu Z, Hu G, Yang X. The Prevalence of Overweight and Obesity and Related Metabolic Abnormalities
among Children and Adolescents in China (Chapter 3). In: Segel CM. Children Obesity: Risk Factors,
Health Effects and Prevention. Nova Science Publishers 2011: 41-58.
160. Hu G. The gender-specific impact of diabetes on the risk of cardiovascular disease (Chapter 5). In:
Swahn EI. Diabetes in Women. Nova Science Publishers 2010: 83-100.
161. Hu G. Diabetes and women’s stroke risk (chapter 17). In: Berhardt LV ed. Advances in Medicine and
Biology. Volume 1. Nova Science Publishers 2010: 393-404.
162. Hu G, Tuomilehto J. Diet and exercise in the prevention and treatment of diabetes and coronary heart
disease (Chapter 3). In: Toth PP ed. The Year in Lipid Disorders, Volume 2. Atlas Medical Publishing
Ltd 2010: 46-59.
163. Hu G. Diabetes and the risk of coronary disease among women (Chapter 4). In: Lardner BV and
Pennelton HR ed. Heart Disease in Women. Nova Science Publishers 2009: 75-85.
164. Hu G, Lakka TA, Barengo NC, Tuomilehto J. Exercise and type 2 diabetes prevention (Chapter 5). In:
Lignalli AT ed. Handbook of Type II Diabetes in the Middle Aged and Elderly. Nova Science Publishers
2009: 93-111.
165. Hu G, Lakka TA, Tuomilehto J. Physical activity, fitness and prevention of type 2 diabetes (Chapter
11). In: Lee IM ed. Epidemiologic Methods in Physical Activity Studies. Oxford University Press 2009:
201-224.
166. Hu G. Exercise and women’s health: results from FIN-MONICA study (Chapter 10). In: Allerton LT,
Rutherfode GP ed. Exercise and Women’s Health: New Research. Nova Science Publishers 2008:
213-230.
167. Hu G, Lakka TA, Lakka HM, Tuomilehto J. Overweight, physical inactivity, insulin resistance, impaired
glucose tolerance, diabetes, the metabolic syndrome and cardiovascular risk (Chapter 6). In: Craham
IM, D’agostino RB ed. Therapeutic Strategies in Cardiovascular Risk. Atlas Medical Publishing Ltd
2008: 77-100.
168. Yu ZJ, Hu G. Prevalence of the metabolic syndrome and its relation to risks for cardiovascular disease
(Chapter 3). In: Batone TE ed. Metabolic Syndrome Research Trends. Nova Science Publishers 2008:
89-103.
169. Hu G, Lakka TA, Lakka HM, Tuomilehto J. Obesity, physical activity, and nutrition in the metabolic
syndrome (Chapter 9). In: Krentz AJ, Wong ND ed. Metabolic Syndrome and Cardiovascular Disease.
Epidemiology, Assessment, and Management. Informa Healthcare, New York 2007: 241-277.
170. Hu G, Tuomilehto J. Lifestyle and outcome among patients with type 2 diabetes. In: Crepaldi G,
Tiengo A, Avogaro A ed. The metabolic syndrome: the road map from inflammation to cardiovascular
disease. International Congress Series 2007; 1303: 160-171.
171. Hu G, Tuomilehto J. Diet and exercise in the prevention and treatment of diabetes and coronary heart
disease (Chapter 3). In: Packard CJ ed. The Year in Lipid Disorders, Volume 1. Atlas Medical
Publishing Ltd 2007: 47-66.
172. Hu G, Yu ZJ. Physical activity and cardiovascular risk factors in China (Chapter 8). In: Saylor CP ed.
Weight Loss, Exercise and Health Research. Nova Science Publishers 2006; 179-194.
173. Hu G. The SuRF Report 2 (China). In: World Health Organization ed. Surveillance of Chronic Disease
Risk Factors: Country-level Data and Comparable Estimates. World Health Organization 2005.
174. Hu G, Qiao Q, Tuomilehto J. Metabolic syndrome, diabetes and coronary heart disease (Chapter 21).
In: Marmot M, Elliott P ed. Coronary Heart Disease Epidemiology, Second Edition. Oxford University
Press 2005: 311-330.
175. Tuomilehto J, Hu G, Qiao Q. Management of cardiovascular risk factors in patients with metabolic
syndrome and type 2 diabetes (Chapter 5). In: Rosano G ed. Diabetes and Cardiovascular Disease.
Wolters Kluwer 2005: 39-47.
176. Bidel S, Hu G, Tuomilehto J. Coffee and risk of type 2 diabetes. Proceedings of The Association
Scientifique Internationale pour le Café (ASIC) Conferences: 20th International Scientific Colloquium
on Coffee. Bangalore India, 2004.
177. Hu G. The SuRF Report 1 (China). In: World Health Organization ed. Surveillance of Risk Factors
Related to Non-communicable Diseases: Current Status of Global Data. World Health Organization
2003.
178. Hu G, Lindström J, Tuomilehto J. Prevention of type 2 diabetes by exercise intervention. In: Cranston
I, Hopkins D, Wilding J, Williams G ed. Diabetes. The Royal Society of Medicine, 2003: 20: 91-96.
179. Qu XS, "Lifestyle, Behaviour and Health" (two chapters by Hu G). Tianjin Science and Technology
Press. 1994 (in Chinese).
Other Articles Not Peer Reviewed
180. Hu G, Tuomilehto J. Joint effect of physical activity and obesity on the risk of heart failure. e-journal of
Cardiology Practice 2010; 8: 29.
181. Hu G, Tuomilehto J. Physical activity cuts stroke risk. e-journal of Cardiology Practice 2006; 4: 25.
182. Hu G, Tuomilehto J. Hypertension combined with type 2 diabetes increases the risk of stroke. ejournal of Cardiology Practice 2006; 4: 27.
183. Hu G, Jousilahti, Tuomilehto J. Exercise can reduce cardiovascular disease in people with type 2
diabetes. e-journal of Cardiology Practice 2005; 3: 31.
184. Hu G, Tuomilehto J. The impact of diabetes and myocardial infarction on mortality from coronary heart
disease. e-journal of Cardiology Practice 2004; 2: 31.
185. Hu G, Tuomilehto J. Asymptomatic diabetes and cardiovascular risk. e-journal of Cardiology Practice
2003; 1: 6.
Submitted Manuscripts
186. Dong L, Liu E, Guo J, Pan L, Li B, Leng J, Zhang C, Zhang Y, Li N, Hu G. Maternal fasting glucose
levels at 4-12 gestational weeks with offspring growth and development in early infancy.
187. Katzmarzyk PT, Barreira TV, Broyles ST, Champagne CM, Chaput JP, Fogelholm M, Hu G, Johnson
WD, Kurpad A, Lambert EV, Maher C, Maia J, Matsudo V, Olds T, Onywera V, Kuriyan R, Sarmiento
OL, Standage M, Tremblay MS, Tudor-Locke C, Zhao P, Church TS. The International Study of
Childhood Obesity, Lifestyle and the Environment (ISCOLE): Design and Methods.
188. Li N, Liu E, Guo J, Pan L, Li B, Wang P, Liu J, Wang Y, Liu G, Hu G. Maternal pre-pregnancy body
mass index and gestational weight gain on pregnancy outcomes.
189. Li N, Liu E, Guo J, Pan L, Li B, Wang P, Liu J, Wang Y, Liu G, Hu G. Maternal pre-pregnancy body
mass index and gestational weight gain on pregnancy outcomes.
190. Li X, Zhang Y, Su D, Li D, Ding D, Hong C, Zhang J, Lv X, Wang M, Xia M, Qiu J, Hu G, Ling W.
Cardiometabolic risk factors in southern Chinese population with coronary heart disease: the
Guangzhou Coronary Heart Disease Cohort (GCHDC).
191. Liu X, Liu G, Wang P, Huang Y, Liu E, Li D, Ren S, Pan L, Li N, Hu G. Prevalence of congenital heart
disease and its related risk factors among 90,796 Chinese infants aged less than 6 months in Tianjin.
192. Li N, Liu N, Sun S, Guo J, Pan L, Wang P, Liu J, Tan L, Liu G, Hu G. Birth weight and overweight or
obesity risk in children under 3 years in China.
193. Shi Z, Hu XS, Yuan BJ, Hu G, Pan XQ, Dai Y, Holmboe-Ottesen G, Byles JE. Association between
different kinds of physical activity and hyperglycemia among Chinese adults.
194. Shi ZM, Yuan BJ, He GL, Xu ZZ, Hu G. No change in prevalence of overweight and obesity among
adolescents from 2002 to 2007 in Jiangsu Province China. Public Health Nutrition.
195. Yang X, Tian HG，Zhang FX, Liu G, Dong L, Zhang C, Leng J, Zhang P, Yu Z, Hu G, Chan JC. A
randomized translational study to examine the effects of shared care versus usual care in
management of gestational diabetes in China: Study design and methods.
196. Wang Y, Katzmarzyk PT, Horswell R, Zhao W, Li W, Johnson J, Ryan DH, Hu G. Racial disparities in
the control status of cardiovascular risk factors in a diabetic underinsured population.
197. Wang Y, Katzmarzyk PT, Horswell R, Zhao W, Johnson J, Cefalu WT, Hu G. Comparison of heart
failure risk stratification performance of the CKD-EPI equation and the MDRD study equation for
estimated glomerular filtration rate in patients with type 2 diabetes.
198. Zhang C, Liu H, Zhang S, Wang L, Li N, Leng J, Li Y, Liu G, Fan X, Yu Z, Yang X, Baccarelli AA, Hou
L, Hu G. Maternal glucose during pregnancy and after delivery in women with gestational diabetes
mellitus on overweight status of their children.
199. Zhao W, Katzmarzyk PT, Horswell R, Wang Y, Johnson J, Hu G. HbA1c and heart failure risk among
diabetic patients.
200. Zhao W, Katzmarzyk PT, Horswell R, Wang Y, Johnson J, Heymsfield SB, Cefalu WT, Ryan DH, Hu
G. Blood Pressure and Heart Failure Risk among Diabetic Patients.
Number of citations: 3800
h-index: 33
ABSTRACTS AT PROFESSIONAL MEETINGS:
Oral Presentation:
1. Zhang C，Li Y, Wang L, Xin S, Li W, Li M, Li W, Leng J, Yu Z, Hu G, Chan JC, Tian H Yang X.
Prevalence of gestational diabetes mellitus diagnosed by the IADPSG’s criteria and the WHO’s criteria
in urban Tianjin, China. World Diabetes Congress, Melbourne, Australia, December 2-6, 2013.
2. Hu G. Lifestyle factors and the risk of stroke. 17th World Congress on Heart Disease, Annual Scientific
Sessions 2012, Toronto, ON, Canada, July 27-30, 2012.
3. Hu G, Tian HG, Zhang F, Liu H, Zhang C, Zhang S, Liu G, Yu Z, Yang X, Qi L, Zhang CL, Wang H, Li
M, Leng J, Wang L, Li Y, Dong L, Tuomilehto J. Tianjin Gestational Diabetes Mellitus Prevention
Program: Study design, methods, and 1-year interim report on the feasibility of lifestyle intervention
program. American Diabetes Association’s 72nd Scientific Sessions, Philadelphia, Pennsylvania, June
8-12, 2012.
4. Jousilahti P, Wang Y, Hu, G, Tuomilehto J, Antikainen R. Lifestyle traits predict the development of
hypertension: a large prospective population-based cohort study in Finland. European Society of
Cardiology Congress 2012, Munich, Germany. August 25-29, 2012.
5. Katzmarzyk PT, Church TS, Chaput JP, Hu G, Kurpad A, Lambert EV, Maia J, Matsudo V, Olds T,
Onywera V, Sarmiento OL, Standage M, Tremblay MS, Tudor-Locke C, Zhao P. The International Study
of Childhood Obesity, Lifestyle and the Environment (ISCOLE). Fourth International Congress on
Physical Activity and Public Health, Sydney, Australia, October 31 – November 3, 2012.
6. Wang Y, Hu G, Tuomilehto J, Jousilahti P. Lifestyle factors predict further development of diabetes: A
large prospective population based-study in Finland. American Heart Association 2012 Scientific
Sessions, Los Angeles, California, November 3-7, 2012.
7. Zhang S, Liu H, Zhang C, Tang Z, Li N, Wang S, Liu G, Hu G. Maternal glucose in pregnancy and after
delivery in GDM mothers on obesity status of their children. American Diabetes Association’s 72nd
Scientific Sessions, Philadelphia, Pennsylvania, June 8-12, 2012.
8. Chen L, Horswell R, Johnson J, Besse J, Hu G. A Simultaneous Testing Model for Screening of
Diabetes among U.S. Adults. 3rd North American Congress of Epidemiology, Montreal, Quebec,
Canada, June 21-24, 2011.
9. Hu G, Wang Y, Jousilahti P, Antikainen R, Mähönen M, Katzmarzyk PT, Tuomilehto J. Lifestyle factors
in relation to heart failure. Joint Conference – 51st Cardiovascular Disease Epidemiology and Prevention
Annual Conference, and Nutrition, Physical Activity and Metabolism Conference, Atlanta, Georgia,
March 22-25, 2011.
10. Zhang Y, Tuomilehto J, Jousilahti P, Hu G. Lifestyle Factors and the Risk of Stroke. Joint Conference –
51st Cardiovascular Disease Epidemiology and Prevention Annual Conference, and Nutrition, Physical
Activity and Metabolism Conference, Atlanta, Georgia, March 22-25, 2011.
11. Hu G, Wang Y, Jousilahti P, Antikainen R, Katzmarzyk PT, Tuomilehto J. Occupational, commuting, and
leisure time physical activity and risk of heart failure. Joint Conference – 50th Cardiovascular Disease
Epidemiology and Prevention Annual Conference, and Nutrition, Physical Activity and Metabolism
Conference, San Francisco, CA. March 2-5, 2010.
12. Hu G, Jousilahti P, Antikainen R, Tuomilehto J. Joint effects of physical activity and body mass index
with the risk of heart failure. Joint Conference – 49th Cardiovascular Disease Epidemiology and
Prevention Annual Conference, and Nutrition, Physical Activity and Metabolism Conference, Palm
Harbor, Florida. March 10-14, 2009.
13. Hu G, Jousilahti P, Salomaa V, Tuomilehto J. Serum C-reactive protein and the risk of type 2 diabetes –
a prospective study in Finland. European Diabetes Epidemiology Group 43rd Annual Meeting, Elsinore,
Denmark. April 5-8, 2008.
14. Shi ZM, Hu XS, Yuan BJ, Hu G, Pan XQ, Dai Y, Holmboe-Ottesen G, Byles JE. Association between
vegetable rich healthy food pattern and metabolic syndrome in China. 1st Diabetes in Asia Study Group
Conference, Kathmandu, Nepal. October 16-18, 2008.
15. Tuomilehto J, Hu G, Jousilahti P. Adiposity and the risk of stroke. European Society of Cardiology
Congress 2007, Vienna, Austria. September 1-5, 2007.
16. Bidel S, Hu G, Qiao Q, Jousilahti P, Antikainen R, Tuomilehto J. Coffee consumption and risk of total
and cardiovascular mortality among patients with type 2 diabetes. European Society of Cardiology
Working group on Epidemiology and Prevention Meeting (EuroPRevent 2006). Athens, Greece. May 1113, 2006.
17. Hu G, Jousilahti P, Antikainen R, Bidel S, Tuomilehto J. The history of diabetes at baseline and the risk
of Parkinson’s disease. European Diabetes Epidemiology Group 41st Annual Meeting, Krakow, Poland.
May 20-23, 2006.
18. Hu G, Jousilahti P, Antikainen R, Bidel S, Tuomilehto J. The history of diabetes at baseline and the risk
of Parkinson’s disease. American Diabetes Association (ADA) 66th Scientific Sessions, Washington, DC,
USA. June 9-13, 2006.
19. Hu G, Sarti C, Jousilahti P, Peltonen M, Qiao Q, Tuomilehto J. Diabetes and hypertension together
increase severely the risk of stroke. 14th European Stroke Conference, Bologna, Italy. 25-28 May, 2005.
20. Barengo NC, Hu G, Lakka TA, Pekkarinen H, Nissinen A, Tuomilehto J. Low physical activity as a
predictor for total and cardiovascular disease mortality in middle-aged men and women in Finland.
International XVIII Puijo Symposium "Physical Activity in Conjunction with Pharmacological Therapy for
Chronic Vascular Diseases", Kuopio, Finland. June 29-July 2, 2005.
21. Hu G, Jousilahti P, Borodulin K, Barengo NC, Lakka TA, Nissinen A, Tuomilehto J. Occupational,
commuting, and leisure-time physical activity in relation to coronary heart disease. International XVIII
Puijo Symposium "Physical Activity in Conjunction with Pharmacological Therapy for Chronic Vascular
Diseases", Kuopio, Finland. June 29-July 2, 2005.
22. Hu G, Jousilahti P, Tuomilehto J. Occupational, commuting, and leisure-time physical activity in relation
to cardiovascular mortality among subjects with high blood pressure. International XVIII Puijo
Symposium "Physical Activity in Conjunction with Pharmacological Therapy for Chronic Vascular
Diseases", Kuopio, Finland. June 29-July 2, 2005.
23. Hu G, Jousilahti P, Tuomilehto J. The impact of diabetes and stroke at baseline and during follow-up on
stroke mortality. European Association for the Study of Diabetes (EASD) 41 st Annual Conference,
Athens, Greece. September 10-15, 2005.
24. Jousilahti P, Hu G, Tuomilehto J. Risk of stroke among 50922 Finnish men and women at different
levels of blood pressure with and without antihypertensive drug treatment. The 13th Nordic Meeting on
Cerebrovascular Diseases, Göteborg, Sweden. September 22-24, 2005.
25. Franks PW, Hu G, Brage S, Luan J, Ekelund U, Tuomilehto J, Wareham NJ for the DECODE Study
group. Syndrome-Z: a new approach to defining clustered metabolic risk. Prediction of early death in
13,000 European men and women from the collaborative DECODE Study. 13th European Congress on
Obesity, Prague, Czech Republic. May 26-29, 2004.
26. Hammar N, Johansson S, Hu G, Peltonen M, Qiao Q, Tuomilehto J for the DECODE Study Group.
Metabolic syndrome, smoking and cardiovascular mortality. European Society of Cardiology Working
group on Epidemiology and Prevention Meeting, Helsingør, Denmark. June 9-12, 2004.
27. Hu G, Jousilahti P, Qiao Q, Katoh S, Tuomilehto J. The impact of diabetes and myocardial infarction at
baseline and during follow-up on mortality from coronary heart disease. European Society of Cardiology
Working group on Epidemiology and Prevention Meeting, Helsingør, Denmark. June 9-12, 2004.
28. Tuomilehto J, Hu G, Jousilahti P, Peltonen M, Lindström J. Urinary sodium, potassium excretion and the
risk of type 2 diabetes: a prospective study in Finland. European Association for the Study of Diabetes
(EASD) 40th Annual Conference, Munich, Germany. September 5-9, 2004.
29. Hu G, Qiao Q, Tuomilehto J for the DECODE Study Group. Effect of smoking on the risk of all-cause,
CVD and cancer mortality by the glucose tolerance status. 12th World Conference on Tobacco or Health,
Helsinki, Finland. August 3-8, 2003.
30. Balkau B, Hu G, Tuomilehto J, Borch-Johnsen K for the DECODE Study Group. A risk score for all
cause and cardiovascular mortality: including glucose as an additional factor. The DECODE Study.
International Diabetes Epidemiology Group 9th Meeting and European Diabetes Epidemiology Group
38th Annual Meeting, Tours, France. August 20-23, 2003.
31. Hu G, Lindström J, Valle T, Eriksson J, Jousilahti P, Silventoinen K, Qiao Q, Tuomilehto J. Physical
activity, body mass index in relation to risk for type 2 diabetes in subjects with normal glucose and
impaired glucose regulation. International Diabetes Epidemiology Group 9th Meeting and European
Diabetes Epidemiology Group 38th Annual Meeting, Tours, France. August 20-23, 2003.
32. Hu G, Tuomilehto J, Qiao Q, Eliasson M, Feskens E, Pyörälä K for the DECODE Study Group.
Hyperinsulinemia as a risk factor for cardiovascular mortality in non-diabetic European men and women.
International Diabetes Epidemiology Group 9th Meeting and European Diabetes Epidemiology Group
38th Annual Meeting, Tours, France. August 20-23, 2003.
33. Nakagami T, Qiao Q, Tuomilehto J, Balkau B, Tajima N, Hu G, Borch-Johnsen K for the DECODA
Study Group. Hyperglycemia and mortality in Japanese and Indian populations-results of the DECODA
follow-up data. International Diabetes Epidemiology Group 9th Meeting and European Diabetes
Epidemiology Group 38th Annual Meeting, Tours, France. August 20-23, 2003.
34. Qiao Q, Hu G, Pyörälä K, Tuomilehto J for the DECODE Study Group. The prevalence of the metabolic
syndrome in Europe using four proposed definitions. International Diabetes Epidemiology Group 9th
Meeting and European Diabetes Epidemiology Group 38th Annual Meeting, Tours, France. August 2023, 2003.
35. Tuomilehto J, Hu G, Lindström J, Jousilahti P. Coffee consumption and risk of type 2 diabetes among
middle-aged Finnish men and women. International Diabetes Epidemiology Group 9th Meeting and
European Diabetes Epidemiology Group 38th Annual Meeting, Tours, France. August 20-23, 2003.
36. Hu G, Tuomilehto J, Jousilahti P. Physical activity, body mass index, waist to hip ratio, and the risk for
all-cause and cardiovascular mortality among middle-aged Finnish men and women. European Society
of Cardiology Congress 2003, Vienna, Austria. August 30-September 3, 2003.
37. Tuomilehto J, Hu G, Qiao Q, Mats Eliasson, Edith Feskens, Pyörälä K for the DECODE Study Group.
Hyperinsulinemia as a risk factor for cardiovascular mortality in non-diabetic European men and women.
European Society of Cardiology Congress 2003, Vienna, Austria. August 30-September 3, 2003.
38. Qiao Q, Hu G, Tuomilehto J, Balkau B, Borch-Johnsen K for the DECODA Study Group. Age and sex
specific prevalence of diabetes and impaired glucose regulation in 10 Asian cohorts. 5th International
Diabetes Federation Western Pacific Region Congress, Beijing, China. May 4-7, 2002.
39. Sarti C, Hu G, Qiao Q, Tuomilehto J for the DECODE Study Group. Mortality from stroke and the
metabolic syndrome in Europe. 11th International Stroke Conference, Geneva, Switzerland. May 29June 1, 2002.
40. Hu G, Qiao Q, Silventoinen K, Eriksson J, Jousilahti P, Lindström J, Valle T, Nissinen A, Tuomilehto J.
Occupational, commuting, leisure time physical activity in relation to risk for type 2 diabetes in middleaged Finnish men and women. European Association for the Study of Diabetes (EASD) 38th Annual
Conference, Budapest, Hungary. September 1-5, 2002.
41. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K for the DECODE Study Group. The
prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality. 3rd
World Congress on Prevention and Diabetes and its Complications, Hong Kong. September 29-October
1, 2002.
42. Hu G, Qiao Q, Tuomilehto J, Eliasson M, Feskens E, Pyörälä K for the DECODE Study Group.
Hyperinsulinemia as an independent risk factor for cardiovascular mortality in both men and women. 3rd
World Congress on Prevention and Diabetes and its Complications, Hong Kong. September 29-October
1, 2002.
43. Hu G, Pekkarinen H, Kumpusalo E, Halonen P, Hänninen O, Tian HG, Guo ZY. Health profiles
comparison between Finnish and Chinese Populations. Finnish General Practice Conference, Helsinki,
Finland. 1999.
44. Hu G, Tian HG, Nan Y. Assessment intake of food and nutrient in different income Chinese urban
people. National Conference on Public Nutrition, China. June, 1996 (in Chinese).
45. Yu ZJ, Nan Y, Yang XL, Hu G, Tian HG. Establishment of salt intake surveillance system for evaluation
of a community-based hypertension control program. National Conference on Public Nutrition, China.
June, 1996 (in Chinese).
46. Nan Y, Yang X, Jia M, Dong Q, Hu G. An analysis of serum lipid levels and their associated factors in
Tianjin residents. Seventh National Conference of Nutrition of China, Chengdu, China. September 1996
(in Chinese).
47. Hu G, Nan Y, Dong Q, Yang X, Tian H. Analysis of nutritional status of Tianjin residents with different
incomes. National Conference on Chronic Diseases Control and Prevention, Tianjin, China. October,
1996 (in Chinese).
48. Yang X, Jia M, Wu J, Hu G. Study on association between nutrition environment and nutrient intake and
nutrition intervention. National Conference on Chronic Diseases Control and Prevention, Tianjin, China.
October, 1996 (in Chinese).
49. Yu ZJ, Nan Y, Hu G, Tian HG. Effects of nutrition intervention on salt consumption in Tianjin. National
Conference on Chronic Diseases Control and Prevention, Tianjin, China. October, 1996 (in Chinese).
50. Yu ZJ, Nan Y, Hu G, Tian HG. Trends in salt consumption in Tianjin: 1992-1994. First National
Conference on Chronic Disease Control and Prevention, Tianjin, China. October, 1994 (in Chinese).
51. Tian HG, Nan Y, Yu ZJ, Hu G. The approach of enhanced food and health food evaluation. Chinese
Food Safety Control Conference, China. October, 1991 (in Chinese).
Poster Presentation:
1. Wang Y, Katzmarzyk PT, Horswell R, Zhao W, Li W, Johnson J, Ryan DH, Hu G. Racial disparities in
the control status of cardiovascular risk factors in a diabetic underinsured population. Joint Conference –
Epidemiology and Prevention/Nutrition, Physical Activity and Metabolism 2013 Scientific Sessions, New
Orleans, Louisiana, March 19-22, 2013.
2. Wang Y, Katzmarzyk PT, Horswell R, Li W, Zhao W, Johnson J, Heymsfield SB, Ryan DH, Hu G.
Kidney function and the risk of cardiovascular disease among Louisiana low income diabetic patients.
Joint Conference – Epidemiology and Prevention/Nutrition, Physical Activity and Metabolism 2013
Scientific Sessions, New Orleans, Louisiana, March 19-22, 2013.
3. Zhang L, Zhang Z, Hu G, Zhang Y. The Finnish Diabetes Risk Score in Detecting Undiagnosed
Diabetes and Pre-Diabetes in U.S. Adults by Gender and Race/Ethnicity. American Diabetes
Association’s 73rd Scientific Sessions, Chicago, Illinois, June 21-25, 2013.
4. Zhao W, Katzmarzyk PT, Horswell R, Wang Y, Li W, Johnson J, Cefalu WT, Ryan DH, Hu G. Blood
pressure and stroke risk among diabetic patients. American Diabetes Association’s 73rd Scientific
Sessions, Chicago, Illinois, June 21-25, 2013.
5. Zhao W, Katzmarzyk PT, Horswell R, Wang Y, Li W, Johnson J, Heymsfield SB, Ryan DH, Hu G.
Aggressive blood pressure control increased coronary heart disease risk in the diabetic patients among
Louisiana. Joint Conference – Epidemiology and Prevention/Nutrition, Physical Activity and Metabolism
2013 Scientific Sessions, New Orleans, Louisiana, March 19-22, 2013.
6. Hu G, Horswell R, Li W, Xiao L, Besse J, Chen H, Ryan DH, Heymsfield SB, Katzmarzyk PT. Body
mass index and the risk of dementia among Louisiana middle and low income diabetic patients.
American Diabetes Association’s 72nd Scientific Sessions, June 8-12, 2012 in Philadelphia,
Pennsylvania, June 8-12, 2012.
7. Hu G, Zhang Y, Jousilahti P, Wang Y, Antikainen R, Tuomilehto J. Lifestyle Factors and
antihypertensive treatment on the Risks of Ischemic and Haemorrhagic Stroke. Joint Conference –
Epidemiology and Prevention/Nutrition, Physical Activity and Metabolism 2012 Scientific Sessions, San
Diego, California, March 13-16, 2012.
8. Wang Y, Tuomilehto J, Jousilahti P, Antikainen R, Mähönen M, Katzmarzyk PT, Hu G. Healthy Lifestyle
Status, Antihypertensive Treatment and the Risk of Heart Failure among Finnish Men and Women. Joint
Conference – Epidemiology and Prevention/Nutrition, Physical Activity and Metabolism 2012 Scientific
Sessions, San Diego, California, March 13-16, 2012.
9. Wang Y, Li W, Chen L, Horswell R, Xie W, Xiao K, Besse J, Johnson J, Katzmarzyk PT, Ryan DH, Hu
G. Racial Disparities in Diabetic Complications in a Middle and Low Income Population of Louisiana.
Joint Conference – Epidemiology and Prevention/Nutrition, Physical Activity and Metabolism 2012
Scientific Sessions, San Diego, California, March 13-16, 2012.
10. Chen L, Wang Y, Xiao K, Horswell R, Hu G. Race and body size influence the risk of hypertension after
the gestational diabetes. Joint Conference – 51st Cardiovascular Disease Epidemiology and Prevention
Annual Conference, and Nutrition, Physical Activity and Metabolism Conference, Atlanta, Georgia,
March 22-25, 2011.
11. Chen L, Zhang Y, Horswell R, Johnson J, Hu G. Evaluation of the Finnish Diabetes Risk Score among
U.S. Adults. American Diabetes Association (ADA) 71st Annual Scientific Sessions, San Diego,
California, June 24-28, 2011.
12. Hu G, Bouchard C, Bray GA, Greenway FL, Johnson WD, Newton Jr RL, Ravussin E, Ryan DH,
Katzmarzyk PT. Trunk versus extremity adiposity and cardiometabolic risk factors in white and African
American adults. Joint Conference – 51st Cardiovascular Disease Epidemiology and Prevention Annual
Conference, and Nutrition, Physical Activity and Metabolism Conference, Atlanta, Georgia, March 22-25,
2011.
13. Wang Y, Chen L, Horswell R, Xiao K, Johnson J, Ryan DH, Hu G. History of Gestational Diabetes
Mellitus Predicts Diabetes among Louisiana women. American Diabetes Association (ADA) 71st Annual
Scientific Sessions, San Diego, California, June 24-28, 2011.
14. Yang X, Tian H, Zhang F, Liu G, Zhang C, Dong L, Leng J, Zhang P, Chan JC, Hu G, Yu Z. A
randomized translational study to examine the effects of shared care versus usual care in management
of gestational diabetes in China. World Diabetes Congress Dubai, Dubai, United Arab Emirates,
December 4-8, 2011.
15. Bowers K, Hu G, Yu Z, Yang X, Klebanoff M, Yeung E, Zhang C. Postnatal weight gain and high blood
pressure among Chinese children. The 43rd Annual Society for Epidemiologic Research (SER) Meeting,
Seattle, Washington. June 23-26, 2010.
16. Chen LW, Zhang Z, Caballero B, Appel LJ, Hu G. Habitual coffee consumption and risk of hypertension:
a meta-analysis of prospective studies. Joint Conference – 50th Cardiovascular Disease Epidemiology
and Prevention Annual Conference, and Nutrition, Physical Activity and Metabolism Conference, San
Francisco, CA. March 2-5, 2010
17. Zhang FX, Dong L, Zhang CP, Li BJ, Wen J, Gao W, Sun SR, Lv FJ, Tian HG, Tuomilehto J, Qi L,
Zhang CL, Yu ZJ, Yang XL, Hu G. Increasing prevalence of gestational diabetes mellitus in Chinese
women from 1999 to 2008. American Diabetes Association (ADA) 70th Annual Scientific Sessions,
Orlando, Florida, June 25-29, 2010.
18. Xiao K, Chen L, Hu G. Increasing prevalence of gestational diabetes mellitus in Louisiana, 1997-2009.
The 43rd Annual Society for Epidemiologic Research (SER) Meeting, Seattle, Washington. June 23-26,
2010.
19. Hu G, Tuomilehto J. Blood pressure and the risk of type 2 diabetes. American Diabetes Association
(ADA) 69th Annual Scientific Sessions, New Orleans, Louisiana. June 6-9, 2009.
20. Hu G, Tuomilehto J, Antikainen R, Jousilahti P. Does serum gamma-glutamyltransferase level predict
the risk of heart failure? Joint Conference – 49th Cardiovascular Disease Epidemiology and Prevention
Annual Conference, and Nutrition, Physical Activity and Metabolism Conference, Palm Harbor, Florida.
March 10-14, 2009.
21. Hu G, Jousilahti P, Tuomilehto J. Associations of total and high-density lipoprotein cholesterol with the
risk of coronary heart disease and total and type-specific stroke. Joint Conference – 48th Cardiovascular
Disease Epidemiology and Prevention Annual Conference, and Nutrition, Physical Activity and
Metabolism Conference, Colorado Springs, Colorado, USA. March 11-15, 2008.
22. Hu G, Jousilahti P, Tuomilehto J. Serum triglycerides and the risk of incident coronary heart disease and
stroke. European Society of Cardiology Congress 2008, Munich, Germany. August 30-September 3,
2008
23. Hu G, Lehtisalo R, Tuomilehto J. Blood pressure and the risk of type 2 diabetes. 5th World Congress on
Prevention of Diabetes and its Complications (WCPD 2008), Helsinki, Finland. June 1-4, 2008.
24. Jousilahti P, Tuomilehto, Hu G, Sundvall J, Salomaa V. Sensitive C-reactive protein and the risk of type
2 diabetes mellitus – a prospective study in Finland. Joint Conference – 48th Cardiovascular Disease
Epidemiology and Prevention Annual Conference, and Nutrition, Physical Activity and Metabolism
Conference, Colorado Springs, Colorado, USA. March 11-15, 2008.
25. Hu G, Tuomilehto J, Silventoinen K, Sarti C, Jousilahti P. Body mass index, waist circumference and
waist-to-hip ratio on the risk of total and type-specific stroke. Joint Conference – 47th Annual Conference
on Cardiovascular Disease Epidemiology and Prevention in association with the Council on Nutrition,
Physical Activity, and Metabolism, Orlando, Florida, USA. February 28-March 3, 2007.
26. Hu G, Jousilahti P, Tuomilehto J. Joint effects of history of hypertension at baseline and type 2 diabetes
at baseline and during follow-up on the risk of coronary heart disease. European Diabetes Epidemiology
Group 42nd Annual Meeting, Cambridge, UK. March 31-April 3, 2007.
27. Hu G, Tuomilehto J, Borodulin K, Jousilahti P. The joint effect of physical activity and Framingham risk
score on coronary heart disease risk. Joint Conference – 46th Annual Conference on Cardiovascular
Disease Epidemiology and Prevention in association with Council on Nutrition, Physical Activity, and
Metabolism, Phoenix, Arizona, USA. March 2-5, 2006.
28. Hu G, Jousilahti P, Tuomilehto J. 10-year trends in prevalence of the metabolic syndrome among
Finnish adults. European Association for the Study of Diabetes (EASD) 42nd Annual Conference,
Copenhagen-Malmoe, Denmark-Sweden. September 14-17, 2006.
29. Hu G, Jousilahti P, Qiao Q, Peltonen M, Katoh S, Tuomilehto J. The impact of diabetes and myocardial
infarction at baseline and during follow-up on mortality from all causes and coronary heart disease.
European Diabetes Epidemiology Group 40th Annual Meeting, Siofok, Hungary. April 2-5, 2005.
30. Nakagami T, Qiao Q, Tuomilehto J, Balkau B, Tajima N, Hu G, Borch-Johnsen K for the DECODA Study
Group. Screen detected diabetes, hypertension and hypercholesteremia as predictors of fatal
cardiovascular disease in five populations of Asian origin. European Diabetes Epidemiology Group 40th
Annual Meeting, Siofok, Hungary. April 2-5, 2005.
31. Hu G, Eliasson M, Peltonen M, Stegmayr B, Qiao Q, Tuomilehto J. The metabolic syndrome and the risk
of cardiovascular disease: assessment of four suggested definitions of the metabolic syndrome. 1 st
International Congress on `Prediabetes` and the Metabolic Syndrome - Epidemiology, Management and
Prevention of Diabetes and Cardiovascular Disease, Berlin, Germany. April 13-16, 2005.
32. Hu G, Jousilahti P, Peltonen M, Qiao Q, Tuomilehto J. The Metabolic Syndrome and Incident Diabetes:
Assessment of Four Suggested Definitions of the Metabolic Syndrome. American Diabetes Association
(ADA) 65th Annual Scientific Sessions, San Diego, California, USA. June 10-14, 2005.
33. Jousilahti P, Hu G, Peltonen M, Qiao Q, Tuomilehto J. The impact of history of hypertension and
diabetes at baseline on the risk of stroke incidence and stroke mortality. American Diabetes Association
(ADA) 65th Annual Scientific Sessions, San Diego, California, USA. June 10-14, 2005.
34. Jousilahti P, Hu G, Borodulin K, Tuomilehto J. Occupational, commuting and leisure time physical
activity and cardiovascular disease mortality among hypertensive subjects - A prospective follow-up of
26723 Finnish men and women. American Heart Association 2005 Annual Scientific Sessions, Dallas,
Texas, USA. November 13-16, 2005.
35. Hu G, Eriksson J, Barengo NC, Lakka TA, Valle T, Nissinen A, Jousilahti P, Tuomilehto J. Occupational,
commuting, and leisure time physical activity in relation to total and cardiovascular mortality among
Finnish subjects with type 2 diabetes. European Diabetes Epidemiology Group 39th Annual Meeting,
Vietri Sul Mare, Italy. April 24-27, 2004.
36. Hu G, Jousilahti P, Barengo NC, Qiao Q, Lakka TA, Tuomilehto J. Physical activity protects against
cardiovascular mortality among middle-aged men and women with type 2 diabetes. European
Association for the Study of Diabetes (EASD) 40th Annual Conference, Munich, Germany. September 59, 2004.
37. Nakagami T, Qiao Q, Tuomilehto J, Hu G, Balkau B, Tajima N, Borch-Johnsen K for the DECODA
Study Group. Prevalence of the metabolic syndrome and its impact on all-cause and cardiovascular
mortality in three Asian origin populations. European Association for the Study of Diabetes (EASD) 40th
Annual Conference, Munich, Germany. September 5-9, 2004.
38. Qiao Q, Hu G, Peltonen M, Tuomilehto J for the DECODE Study Group. Risk of death from all-cause
and cardiovascular disease (CVD) related to the different definitions of the metabolic syndrome (MS)
and to individual metabolic abnormalities. European Association for the Study of Diabetes (EASD) 40th
Annual Conference, Munich, Germany. September 5-9, 2004.
39. Wang JJ, Hu G, Miettinen M, Tuomilehto J. The metabolic syndrome and incident diabetes: Assessment
of four suggested definitions of the metabolic syndrome in a Chinese population with high post-prandial
glucose. European Association for the Study of Diabetes (EASD) 40th Annual Conference, Munich,
Germany. September 5-9, 2004.
40. Jousilahti P, Hu G, Tuomilehto. Single and joint effects of obesity and physical activity on stroke risk.
American Heart Association 2004 Annual Scientific Sessions, New Orleans, USA. November 6-10,
2004.
41. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Johansson S, Kennerfalk A, Pyörälä K for the
DECODE Study Group. The metabolic syndrome and total and cardiovascular mortality in non-diabetic
European men and women. 18th International Diabetes Federation (IDF) Congress, Paris, France.
August 24-29, 2003.
42. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K for the DECODE Study Group. Gender
difference in cardiovascular and all-cause mortality related to hyperglycaemia and newly diagnosed
diabetes. European Diabetes Epidemiology Group 37th Annual Meeting, St Catherine’s College, Oxford,
UK. March 23-26, 2002.
43. Qiao Q, Hu G, Tuomilehto J, Balkau B, Borch-Johnsen K for the DECODE Study Group. Age and sex
specific prevalence of diabetes and impaired glucose regulation in 13 European cohorts. European
Diabetes Epidemiology Group 37th Annual Meeting, St Catherine’s College, Oxford, UK. March 23-26,
2002.
44. Nakagami T, Qiao Q, Carstensen B, Nøhr-Hansen C, Hu G, Tuomilehto J, Balkau B, Borch-Johnsen K
for the DECODA Study Group. Age, BMI and Type 2 Diabetes – association modified by ethnicity.
European Association for the Study of Diabetes (EASD) 38th Annual Conference, Budapest, Hungary.
September 1-5, 2002.
45. Hu G, Pekkarinen H, Hanninen O, Guo ZY, Tian HG. A comparison of dietary and non-dietary factors in
overweight and normal weight Chinese people. 15-Year Anniversary Symposium of the Department of
Clinical Nutrition, Kuopio, Finland. March 25-26, 1999.
46. Yang X, Hsu-Hage B. H-H, Tian HG, Hu G, Dong Q, Wu Z, Wahlqvist ML. The role of income and
education in food consumption and nutrient intake in a Chinese population. Twenty-first Annual
Scientific Meeting of the Nutrition Society of Australia, Brisbane, Australia. November 30-December 2,
1997.
Publications:
1. Chen L, Wang Y, Xiao K, Horswell R, Zhang C, Hu G. Risk of hypertension after the gestational
diabetes: findings from a large multi-ethnicity cohort study in Louisiana. American Diabetes Association
(ADA) 71st Annual Scientific Sessions, San Diego, California, June 24-28, 2011.
2. Wang Y, Li, W, Chen L, Horswell R, Xiao K, Johnson J, Ryan DH, Hu G. Prevalence of diabetes in
Louisiana from 1998 to 2009. American Diabetes Association (ADA) 71st Annual Scientific Sessions,
San Diego, California, June 24-28, 2011.
ADDITIONAL INFORMATION
Main research interests:
 Different kinds of physical activity (occupational, commuting, and leisure time), obesity and their
combined effects on the risk of several chronic diseases, including type 2 diabetes,
hypertension, coronary heart disease, heart failure, stroke, and cancer;
 Insulin resistance, glucose tolerance, the metabolic syndrome and the risks of type 2 diabetes,
cardiovascular disease and cancer;
 The independent and joint effects of diabetes, myocardial infraction, stroke, hypertension and
other cardiovascular risk factors on the risk of cardiovascular mortality;
 Coffee and alcohol consumption and the risk of several chronic diseases, including type 2
diabetes, hypertension, coronary heart disease, heart failure, stroke, and cancer;
 Dietary factors and the risk of several chronic diseases, including obesity, hypertension, type 2
diabetes, coronary heart disease, heart failure, Parkinson’s disease and different types of
cancer;
 The interaction in lifestyle and genetic factors on the risk of type 2 diabetes in women with
gestational diabetes.